$sgma 2024 Q3 10-Q

Concept	2024 Q3
Revenue	$84.78M
YoY Change	-13.61%
Cost Of Revenue	$78.37M
YoY Change	-11.42%
Gross Profit	$6.405M
YoY Change	-33.63%
Gross Profit Margin	7.56%
Selling, General & Admin	$6.624M
YoY Change	-3.2%
% of Gross Profit	103.41%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.506M
YoY Change	-4.67%
% of Gross Profit	23.51%
Operating Expenses	$6.624M
YoY Change	-3.2%
Operating Profit	-$218.7K
YoY Change	-107.79%
Interest Expense	$2.268M
YoY Change	-16.58%
% of Operating Profit
Other Income/Expense, Net	$0.00
YoY Change	-100.0%
Pretax Income	-$2.487M
YoY Change	-2403.5%
Income Tax	$802.2K
% Of Pretax Income
Net Earnings	-$3.289M
YoY Change	-1354.93%
Net Earnings / Revenue	-3.88%
Basic Earnings Per Share	-$0.54
Diluted Earnings Per Share	-$0.54
COMMON SHARES
Basic Shares Outstanding	6.119M
Diluted Shares Outstanding	6.119M

Concept	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.303M
YoY Change	220.46%
Cash & Equivalents	$5.303M
Short-Term Investments
Other Short-Term Assets	$1.674M
YoY Change	-3.57%
Inventory	$115.7M
Prepaid Expenses
Receivables	$35.72M
Other Receivables	$2.521M
Total Short-Term Assets	$167.9M
YoY Change	-21.02%
LONG-TERM ASSETS
Property, Plant & Equipment	$32.50M
YoY Change	-9.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.214M
YoY Change	-1.76%
Total Long-Term Assets	$50.95M
YoY Change	7.82%
TOTAL ASSETS
Total Short-Term Assets	$167.9M
Total Long-Term Assets	$50.95M
Total Assets	$218.8M
YoY Change	-15.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$46.62M
YoY Change	-37.53%
Accrued Expenses	$2.143M
YoY Change	-30.52%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due	$67.79M
YoY Change	44.28%
Total Short-Term Liabilities	$145.4M
YoY Change	1.36%
LONG-TERM LIABILITIES
Long-Term Debt	$2.958M
YoY Change	-92.71%
Other Long-Term Liabilities	$105.2K
YoY Change	3.57%
Total Long-Term Liabilities	$10.57M
YoY Change	-77.9%
TOTAL LIABILITIES
Total Short-Term Liabilities	$145.4M
Total Long-Term Liabilities	$10.57M
Total Liabilities	$156.0M
YoY Change	-18.46%
SHAREHOLDERS EQUITY
Retained Earnings	$20.27M
YoY Change	-22.95%
Common Stock	$42.59M
YoY Change	0.84%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$62.85M
YoY Change
Total Liabilities & Shareholders Equity	$218.8M
YoY Change	-15.78%

Concept	2024 Q3
OPERATING ACTIVITIES
Net Income	-$3.289M
YoY Change	-1354.93%
Depreciation, Depletion And Amortization	$1.506M
YoY Change	-4.67%
Cash From Operating Activities	$2.628M
YoY Change	-66.09%
INVESTING ACTIVITIES
Capital Expenditures	$167.8K
YoY Change	-73.02%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$167.8K
YoY Change	-73.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	426.1K
YoY Change	-106.77%
NET CHANGE
Cash From Operating Activities	2.628M
Cash From Investing Activities	-167.8K
Cash From Financing Activities	426.1K
Net Change In Cash	2.886M
YoY Change	245.31%
FREE CASH FLOW
Cash From Operating Activities	$2.628M
Capital Expenditures	$167.8K
Free Cash Flow	$2.460M
YoY Change	-65.49%

Frame	Concept Type	Concept / XBRL Key	Value
CY2024Q3	dei	Amendment Flag AmendmentFlag	false
CY2024Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--04-30
CY2024Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2025
CY2024Q3	dei	Entity Central Index Key EntityCentralIndexKey	0000915358
CY2024Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q3	sgma	Proceeds From Equipment Note ProceedsFromEquipmentNote
CY2024Q3	sgma	Purchase Of Property Plant And Equipment Financed Under Capital Leases PurchaseOfPropertyPlantAndEquipmentFinancedUnderCapitalLeases
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2024Q3	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour
CY2024Q3	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue
CY2023Q3	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses
CY2024Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
CY2024Q3	dei	Document Type DocumentType	10-Q
CY2024Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q3	dei	Document Period End Date DocumentPeriodEndDate	2024-07-31
CY2024Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q3	dei	Entity File Number EntityFileNumber	0-23248
CY2024Q3	dei	Entity Registrant Name EntityRegistrantName	SIGMATRON INTERNATIONAL, INC.
CY2024Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	184817
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	262099
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	68537943
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-3289160
CY2024Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	36-3918470
CY2024Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	2201 Landmeier Road
CY2024Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Elk Grove Village
CY2024Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	IL
CY2024Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	60007
CY2024Q3	dei	City Area Code CityAreaCode	847
CY2024Q3	dei	Local Phone Number LocalPhoneNumber	956-8000
CY2024Q3	dei	Security12b Title Security12bTitle	Common Stock $0.01 par value per share
CY2024Q3	dei	Trading Symbol TradingSymbol	SGMA
CY2024Q3	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q3	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6119288
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5303318
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2417360
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	7814
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	59466
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	35724814
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	32043985
CY2024Q3	us-gaap	Inventory Net InventoryNet	115687645
CY2024Q2	us-gaap	Inventory Net InventoryNet	128850901
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1674022
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1886701
CY2024Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	771535
CY2024Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	1716372
CY2024Q3	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	6211685
CY2024Q2	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	6569984
CY2024Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	2521174
CY2024Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	2417316
CY2024Q3	us-gaap	Assets Current AssetsCurrent	167894193
CY2024Q2	us-gaap	Assets Current AssetsCurrent	175902619
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	32497960
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	33755078
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	897567
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	979188
CY2024Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	8752870
CY2024Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	4432210
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7585366
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7463301
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1213762
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1261579
CY2024Q3	sgma	Other Long Term Assets OtherLongTermAssets	18449565
CY2024Q2	sgma	Other Long Term Assets OtherLongTermAssets	14136278
CY2024Q3	us-gaap	Assets Assets	218841718
CY2024Q2	us-gaap	Assets Assets	223793975
CY2024Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	46621825
CY2024Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	50593099
CY2024Q3	sgma	Customer Deposit Current CustomerDepositCurrent	9182867
CY2024Q2	sgma	Customer Deposit Current CustomerDepositCurrent	10738596
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6276555
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6746466
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2143130
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2554260
CY2024Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	4981747
CY2024Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	897847
CY2024Q3	us-gaap	Deferred Income DeferredIncome	3164998
CY2024Q2	us-gaap	Deferred Income DeferredIncome	3111062
CY2024Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	67785664
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	66244227
CY2024Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2087938
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2214127
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3171681
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2789107
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	145416405
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	145888791
CY2024Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2957603
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3339160
CY2024Q3	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	153983
CY2024Q2	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	294993
CY2024Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2660504
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3147447
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4693774
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4958247
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	105182
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	93084
CY2024Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	10571046
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	11832931
CY2024Q3	us-gaap	Liabilities Liabilities	155987451
CY2024Q2	us-gaap	Liabilities Liabilities	157721722
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	12000000
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	12000000
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6119288
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6119288
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6119288
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6119288
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	61193
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	61193
CY2024Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	42524568
CY2024Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	42453394
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	20268506
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	23557666
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	62854267
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	66072253
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	218841718
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	223793975
CY2024Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	84776978
CY2023Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	98130356
CY2024Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	78371784
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	88479136
CY2024Q3	us-gaap	Gross Profit GrossProfit	6405194
CY2023Q3	us-gaap	Gross Profit GrossProfit	9651220
CY2024Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6623866
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6842805
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-218672
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	2808415
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	18627
CY2024Q3	us-gaap	Interest Expense InterestExpense	2268275
CY2023Q3	us-gaap	Interest Expense InterestExpense	2719078
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2486947
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	107964
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	802213
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-154135
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-3289160
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	262099
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.54
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.54
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6119288
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6091288
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6119288
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6100284
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	66072253
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	71174
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-3289160
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	62854267
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	68091027
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	184817
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	262099
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	68537943
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-3289160
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	262099
CY2024Q3	sgma	Depreciation And Amortization Expense DepreciationAndAmortizationExpense	1424092
CY2023Q3	sgma	Depreciation And Amortization Expense DepreciationAndAmortizationExpense	1496034
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	71174
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	184817
CY2024Q3	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	51652
CY2024Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4320660
CY2023Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	180213
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	81621
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	83415
CY2024Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	120644
CY2023Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	116745
CY2024Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-839
CY2023Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-43286
CY2024Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3732481
CY2023Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2058165
CY2024Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-13163256
CY2023Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-7092926
CY2024Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-632335
CY2023Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	611805
CY2024Q3	sgma	Increase Decrease In Right Of Use Assets IncreaseDecreaseInRightOfUseAssets	122065
CY2023Q3	sgma	Increase Decrease In Right Of Use Assets IncreaseDecreaseInRightOfUseAssets	-801201
CY2024Q3	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-944837
CY2023Q3	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-368218
CY2024Q3	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	3942890
CY2023Q3	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1161108
CY2024Q3	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-3971274
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-10241474
CY2024Q3	sgma	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	-1555729
CY2023Q3	sgma	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	9717955
CY2024Q3	sgma	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-118101
CY2023Q3	sgma	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	779898
CY2024Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-986341
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	660153
CY2024Q3	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	53936
CY2023Q3	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-2520928
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	262099
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	71174
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	184817
CY2024Q3	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	51652
CY2024Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4320660
CY2023Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	180213
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	81621
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	83415
CY2024Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	120644
CY2023Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	116745
CY2024Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-839
CY2023Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-43286
CY2024Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3732481
CY2023Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2058165
CY2024Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-13163256
CY2023Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-7092926
CY2024Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-632335
CY2023Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	611805
CY2024Q3	sgma	Increase Decrease In Right Of Use Assets IncreaseDecreaseInRightOfUseAssets	122065
CY2023Q3	sgma	Increase Decrease In Right Of Use Assets IncreaseDecreaseInRightOfUseAssets	-801201
CY2024Q3	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-944837
CY2023Q3	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-368218
CY2024Q3	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	3942890
CY2023Q3	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1161108
CY2024Q3	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-3971274
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-10241474
CY2024Q3	sgma	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	-1555729
CY2023Q3	sgma	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	9717955
CY2024Q3	sgma	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-118101
CY2023Q3	sgma	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	779898
CY2024Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-986341
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	660153
CY2024Q3	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	53936
CY2023Q3	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-2520928
CY2024Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2627667
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7750014
CY2024Q3	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	167813
CY2023Q3	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	621929
CY2024Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-167813
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-621929
CY2023Q3	sgma	Proceeds From Equipment Note ProceedsFromEquipmentNote	783461
CY2024Q3	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	613132
CY2023Q3	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	428105
CY2024Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2627667
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7750014
CY2024Q3	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	167813
CY2023Q3	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	621929
CY2024Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-167813
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-621929
CY2023Q3	sgma	Proceeds From Equipment Note ProceedsFromEquipmentNote	783461
CY2024Q3	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	613132
CY2023Q3	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	428105
CY2024Q3	sgma	Repayments Of Equipment Note RepaymentsOfEquipmentNote	383600
CY2023Q3	sgma	Repayments Of Equipment Note RepaymentsOfEquipmentNote	278250
CY2024Q3	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	13103
CY2023Q3	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	12372
CY2024Q3	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	250000
CY2023Q3	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	250000
CY2024Q3	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	87317346
CY2023Q3	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	103905204
CY2024Q3	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	85631407
CY2023Q3	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	109632319
CY2023Q3	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	379942
CY2024Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	426104
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6292323
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	2885958
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	835762
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2417360
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	819129
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5303318
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1654891
CY2024Q3	us-gaap	Interest Paid Net InterestPaidNet	2217494
CY2023Q3	us-gaap	Interest Paid Net InterestPaidNet	2583509
CY2024Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	383245
CY2023Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	434038
CY2023Q3	sgma	Purchase Of Property Plant And Equipment Financed Under Capital Leases PurchaseOfPropertyPlantAndEquipmentFinancedUnderCapitalLeases	1032351
CY2024Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	936399
CY2023Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1531
CY2024Q3	us-gaap	Nature Of Operations NatureOfOperations	<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Note A - D</span><span id="NOTES_TO_CONSOLIDATED_FS" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">escription of the Business</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">SigmaTron International, Inc., its subsidiaries, foreign enterprises and international procurement office (collectively, “SigmaTron” or the “Company”) operates in </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">one</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> reportable segment as an independent provider of electronic manufacturing services (“EMS”). EMS includes printed circuit board assemblies, electro-mechanical subassemblies and completely assembled (box-build) electronic products. In connection with the production of assembled products, EMS also provides services to its customers, including (1) automatic and manual assembly and testing of products; (2) material sourcing and procurement; (3) manufacturing and test engineering support; (4) design services; (5) warehousing and distribution services; (6) assistance in obtaining product approval from governmental and other regulatory bodies and (7) compliance reporting. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company’s primary secured credit agreements, being the Amended and Restated Credit Agreement dated as of July 18, 2022 (as amended, restated, supplemented or otherwise modified from time to time, the “JPM Credit Agreement”) by and among the Company, the other loan party thereto and JPMorgan Chase Bank, N.A, as lender (“JPM”), and the Credit Agreement dated as of July 18, 2022 (as amended, restated, supplemented or otherwise modified from time to time, the “Term Loan Agreement” and together with the JPM Credit Agreement, the “Credit Agreements”) by and among the Company, the financial institutions identified therein (the “TCW Lenders”) and TCW Asset Management Company LLC, as administrative agent for the TCW Lenders (in such capacity, the “Agent,” and collectively with the TCW Lenders and JPM, the “Lender Parties”)</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">contain financial covenants relating to (i) the Fixed Charge Coverage Ratio (as defined in the Credit Agreements), which is the ratio of the Company’s fixed payments on its indebtedness made during any fiscal period minus non-financed capital expenditures to EBITDA (as defined in the Credit Agreements) and (ii) the Total Debt to EBITDA Ratio (as defined in the Credit Agreements), which is the ratio of the Company’s borrowed money or letters of credit to EBITDA.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">As of August 19, 2024, the Company was not in compliance with the financial covenants under the Credit Agreements as follows: </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the Fixed Charge Coverage Ratio for each of the twelve month periods ending on April 30, 2024, May 31, 2024, June 30, 2024, and July 31, 2024 was less than </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1.10</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">:1.00, the Total Debt to EBITDA Ratio for the twelve month period ending on April 30, 2024 was greater than </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">4.50</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">:1.00, and the Total Debt to EBITDA Ratio for the twelve month period ending on July 31, 2024 was greater than </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">4.25</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">:1.00 (collectively, the “2024 Covenant Defaults”). In addition, the Company received a </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">delinquency</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.5pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">notification</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.45pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">letter</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.25pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">from</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.15pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Nasdaq,</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.3pt;margin: 0;padding: 0;"> dated </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">August 16, 2024, </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">indicating</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.4pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">that </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.15pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Company</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.4pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">was</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.2pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">not</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.15pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">in</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.1pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">compliance</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.45pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">with</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.2pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.15pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">continued</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.4pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">listing</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.25pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">requirements</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.5pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">of</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.1pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Nasdaq</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.3pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">for</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.15pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">failing</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.3pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">to</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.1pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">timely</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.3pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">file</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.15pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.15pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Company</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;">’</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">s</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.45pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">F</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.05pt;margin: 0;padding: 0;">o</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">rm</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.25pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">10-</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> K annual report</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.25pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">for</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.15pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.15pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">fiscal year</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.3pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">ended</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.25pt;margin: 0;padding: 0;"> April</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.35pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">30,</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.15pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2024.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.05pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">This</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.2pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">notification</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.45pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">also</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.2pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">constituted</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.45pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">a</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.1pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">default</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.3pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">under</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.25pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.15pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Credit</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Agreements (collectively with the 2024 Covenant Defaults, the “2024 Defaults”). The Company had 60 days from the date of the Nasdaq delinquency notice, or until October 15, 2024, to file a plan with Nasdaq to regain compliance. On September 10, 2024, the Company received a notification letter from Nasdaq indicating that the Company had regained compliance with the applicable continued listing requirements based on </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.15pt;margin: 0;padding: 0;"> filing of the </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Company</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;">’</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">s</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.45pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">F</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.05pt;margin: 0;padding: 0;">o</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">rm</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.25pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">10-</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">K annual report</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.25pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">for</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.15pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.15pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">fiscal year</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.3pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">ended</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.25pt;margin: 0;padding: 0;"> April</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.35pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">30,</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.15pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2024.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Due to the Covenant Defaults, the facilities under the Credit Agreements were classified as current liabilities on the Consolidated Balance Sheet at July 31, 2024 and April 30, 2024. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On August </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">19, 2024 (the “Third Amendment Effective Date”), the Lender Parties waived the 2024 Defaults</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">pursuant to (i) the Waiver and Amendment No. 3 to Credit Agreement (the “JPM Amendment”) between the Company and JPM, and (ii) the Waiver and Amendment No. 3 to Credit </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><h1 dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Note A - Description of the Business - Continued</span></h1><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Agreement (the “TCW Amendment” and together with the JPM Amendment, the “2024 Amendments”) by and </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">among the Company,</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> the TCW Lenders, and the Agent. In consideration of the TCW Amendment, the Company and the Agent also entered into the Third Amendment Fee Letter to the TCW Credit Agreement (the “Fee Letter”) dated as of the Third Amendment Effective Date.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> The 2024 Amendments also amended the financial covenants and certain other terms of the Credit Agreements, including, among other things, that the Company will pursue and close a Replacement Transaction (as defined in the Credit Agreements) to pay the obligations under the Credit Agreements in full no later than September 30, 2025 unless the Company meets certain debt ratios for the twelve month period ending on August 31, 2025. See </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Waivers and Amendments No. 3</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> within Note E – Long-term Debt </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">for more information. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company is taking steps to reduce its debt and cost structure. Most recently, since the beginning of calendar year 2024, these actions include the sale of its Elgin, Illinois property and consolidation of the Elgin operations to the Elk Grove Village, Illinois headquarters, reduction of headcounts at various operations and corporate, and inventory reduction. At this time, it is expected that these results plus the amendments to the financial covenants and other provisions of the Credit Agreements that are included in the 2024 Amendments should poise the Company for compliance. At the same time, the Company continues to explore other strategic initiatives to further reduce its debt to enable it to continue to comply with increasingly stringent financial covenants. Delays or a failure to effectively reduce debt, including due to circumstances outside of our control, could have an adverse effect on our financial position and results of operations</span><span style="white-space:pre-wrap; font-family: 'Segoe UI', 'sans-serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.</span>
CY2024Q3	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2024Q3	sgma	Repayments Of Equipment Note RepaymentsOfEquipmentNote	383600
CY2023Q3	sgma	Repayments Of Equipment Note RepaymentsOfEquipmentNote	278250
CY2024Q3	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	13103
CY2023Q3	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	12372
CY2024Q3	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	250000
CY2023Q3	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	250000
CY2024Q3	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	87317346
CY2023Q3	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	103905204
CY2024Q3	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	85631407
CY2023Q3	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	109632319
CY2023Q3	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	379942
CY2024Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	426104
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6292323
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	2885958
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	835762
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2417360
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	819129
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5303318
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1654891
CY2024Q3	us-gaap	Interest Paid Net InterestPaidNet	2217494
CY2023Q3	us-gaap	Interest Paid Net InterestPaidNet	2583509
CY2024Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	383245
CY2023Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	434038
CY2023Q3	sgma	Purchase Of Property Plant And Equipment Financed Under Capital Leases PurchaseOfPropertyPlantAndEquipmentFinancedUnderCapitalLeases	1032351
CY2024Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	936399
CY2023Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1531
CY2024Q3	us-gaap	Nature Of Operations NatureOfOperations	<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Note A - D</span><span id="NOTES_TO_CONSOLIDATED_FS" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">escription of the Business</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">SigmaTron International, Inc., its subsidiaries, foreign enterprises and international procurement office (collectively, “SigmaTron” or the “Company”) operates in </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">one</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> reportable segment as an independent provider of electronic manufacturing services (“EMS”). EMS includes printed circuit board assemblies, electro-mechanical subassemblies and completely assembled (box-build) electronic products. In connection with the production of assembled products, EMS also provides services to its customers, including (1) automatic and manual assembly and testing of products; (2) material sourcing and procurement; (3) manufacturing and test engineering support; (4) design services; (5) warehousing and distribution services; (6) assistance in obtaining product approval from governmental and other regulatory bodies and (7) compliance reporting. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company’s primary secured credit agreements, being the Amended and Restated Credit Agreement dated as of July 18, 2022 (as amended, restated, supplemented or otherwise modified from time to time, the “JPM Credit Agreement”) by and among the Company, the other loan party thereto and JPMorgan Chase Bank, N.A, as lender (“JPM”), and the Credit Agreement dated as of July 18, 2022 (as amended, restated, supplemented or otherwise modified from time to time, the “Term Loan Agreement” and together with the JPM Credit Agreement, the “Credit Agreements”) by and among the Company, the financial institutions identified therein (the “TCW Lenders”) and TCW Asset Management Company LLC, as administrative agent for the TCW Lenders (in such capacity, the “Agent,” and collectively with the TCW Lenders and JPM, the “Lender Parties”)</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">contain financial covenants relating to (i) the Fixed Charge Coverage Ratio (as defined in the Credit Agreements), which is the ratio of the Company’s fixed payments on its indebtedness made during any fiscal period minus non-financed capital expenditures to EBITDA (as defined in the Credit Agreements) and (ii) the Total Debt to EBITDA Ratio (as defined in the Credit Agreements), which is the ratio of the Company’s borrowed money or letters of credit to EBITDA.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">As of August 19, 2024, the Company was not in compliance with the financial covenants under the Credit Agreements as follows: </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the Fixed Charge Coverage Ratio for each of the twelve month periods ending on April 30, 2024, May 31, 2024, June 30, 2024, and July 31, 2024 was less than </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1.10</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">:1.00, the Total Debt to EBITDA Ratio for the twelve month period ending on April 30, 2024 was greater than </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">4.50</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">:1.00, and the Total Debt to EBITDA Ratio for the twelve month period ending on July 31, 2024 was greater than </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">4.25</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">:1.00 (collectively, the “2024 Covenant Defaults”). In addition, the Company received a </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">delinquency</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.5pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">notification</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.45pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">letter</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.25pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">from</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.15pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Nasdaq,</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.3pt;margin: 0;padding: 0;"> dated </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">August 16, 2024, </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">indicating</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.4pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">that </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.15pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Company</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.4pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">was</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.2pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">not</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.15pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">in</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.1pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">compliance</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.45pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">with</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.2pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.15pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">continued</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.4pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">listing</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.25pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">requirements</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.5pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">of</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.1pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Nasdaq</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.3pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">for</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.15pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">failing</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.3pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">to</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.1pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">timely</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.3pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">file</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.15pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.15pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Company</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;">’</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">s</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.45pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">F</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.05pt;margin: 0;padding: 0;">o</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">rm</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.25pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">10-</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> K annual report</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.25pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">for</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.15pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.15pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">fiscal year</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.3pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">ended</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.25pt;margin: 0;padding: 0;"> April</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.35pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">30,</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.15pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2024.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.05pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">This</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.2pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">notification</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.45pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">also</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.2pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">constituted</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.45pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">a</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.1pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">default</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.3pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">under</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.25pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.15pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Credit</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Agreements (collectively with the 2024 Covenant Defaults, the “2024 Defaults”). The Company had 60 days from the date of the Nasdaq delinquency notice, or until October 15, 2024, to file a plan with Nasdaq to regain compliance. On September 10, 2024, the Company received a notification letter from Nasdaq indicating that the Company had regained compliance with the applicable continued listing requirements based on </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.15pt;margin: 0;padding: 0;"> filing of the </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Company</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;">’</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">s</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.45pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">F</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.05pt;margin: 0;padding: 0;">o</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">rm</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.25pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">10-</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">K annual report</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.25pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">for</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.15pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.15pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">fiscal year</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.3pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">ended</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.25pt;margin: 0;padding: 0;"> April</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.35pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">30,</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;letter-spacing: 0.15pt;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2024.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Due to the Covenant Defaults, the facilities under the Credit Agreements were classified as current liabilities on the Consolidated Balance Sheet at July 31, 2024 and April 30, 2024. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On August </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">19, 2024 (the “Third Amendment Effective Date”), the Lender Parties waived the 2024 Defaults</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">pursuant to (i) the Waiver and Amendment No. 3 to Credit Agreement (the “JPM Amendment”) between the Company and JPM, and (ii) the Waiver and Amendment No. 3 to Credit </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><h1 dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Note A - Description of the Business - Continued</span></h1><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Agreement (the “TCW Amendment” and together with the JPM Amendment, the “2024 Amendments”) by and </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">among the Company,</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> the TCW Lenders, and the Agent. In consideration of the TCW Amendment, the Company and the Agent also entered into the Third Amendment Fee Letter to the TCW Credit Agreement (the “Fee Letter”) dated as of the Third Amendment Effective Date.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> The 2024 Amendments also amended the financial covenants and certain other terms of the Credit Agreements, including, among other things, that the Company will pursue and close a Replacement Transaction (as defined in the Credit Agreements) to pay the obligations under the Credit Agreements in full no later than September 30, 2025 unless the Company meets certain debt ratios for the twelve month period ending on August 31, 2025. See </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Waivers and Amendments No. 3</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> within Note E – Long-term Debt </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">for more information. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company is taking steps to reduce its debt and cost structure. Most recently, since the beginning of calendar year 2024, these actions include the sale of its Elgin, Illinois property and consolidation of the Elgin operations to the Elk Grove Village, Illinois headquarters, reduction of headcounts at various operations and corporate, and inventory reduction. At this time, it is expected that these results plus the amendments to the financial covenants and other provisions of the Credit Agreements that are included in the 2024 Amendments should poise the Company for compliance. At the same time, the Company continues to explore other strategic initiatives to further reduce its debt to enable it to continue to comply with increasingly stringent financial covenants. Delays or a failure to effectively reduce debt, including due to circumstances outside of our control, could have an adverse effect on our financial position and results of operations</span><span style="white-space:pre-wrap; font-family: 'Segoe UI', 'sans-serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.</span>
CY2024Q3	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2024Q3	us-gaap	Basis Of Accounting BasisOfAccounting	<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Note B - Basis of Presentation</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The accompanying unaudited condensed consolidated financial statements of the Company, its subsidiaries, Standard Components de Mexico, S.A., AbleMex S.A. de C.V., Digital Appliance Controls de Mexico, S.A. de C.V., Spitfire Controls (Vietnam) Co. Ltd., and Spitfire Controls (Cayman) Co. Ltd., wholly-owned foreign enterprises Wujiang SigmaTron Electronics Co. Ltd., and Wujiang SigmaTron Electronic Technology Co., Ltd., its international procurement office, SigmaTron International Inc. Taiwan Branch, and Wagz, Inc. (majority of business sold, effective as of April 1, 2023), have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X.</span></p><h4 dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></h4><h4 dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The accompanying unaudited condensed consolidated financial statements do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the three month period ended July 31, 2024 are not necessarily indicative of the results that may be expected for the year ending April 30, 2025. The condensed consolidated balance sheet at April 30, 2024, was derived from audited annual financial statements but does not contain all of the footnote disclosures from the annual financial statements. For further information, refer to the condensed consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended April 30, 2024. </span></h4><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Reclassifications</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Certain amounts recorded in the prior-period consolidated financial statements have been reclassified to conform to the current-period financial statement presentation. These reclassifications had no effect on previously reported results of operations.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p>
CY2024Q3	us-gaap	Basis Of Accounting BasisOfAccounting	<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Note B - Basis of Presentation</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The accompanying unaudited condensed consolidated financial statements of the Company, its subsidiaries, Standard Components de Mexico, S.A., AbleMex S.A. de C.V., Digital Appliance Controls de Mexico, S.A. de C.V., Spitfire Controls (Vietnam) Co. Ltd., and Spitfire Controls (Cayman) Co. Ltd., wholly-owned foreign enterprises Wujiang SigmaTron Electronics Co. Ltd., and Wujiang SigmaTron Electronic Technology Co., Ltd., its international procurement office, SigmaTron International Inc. Taiwan Branch, and Wagz, Inc. (majority of business sold, effective as of April 1, 2023), have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X.</span></p><h4 dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></h4><h4 dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The accompanying unaudited condensed consolidated financial statements do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the three month period ended July 31, 2024 are not necessarily indicative of the results that may be expected for the year ending April 30, 2025. The condensed consolidated balance sheet at April 30, 2024, was derived from audited annual financial statements but does not contain all of the footnote disclosures from the annual financial statements. For further information, refer to the condensed consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended April 30, 2024. </span></h4><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Reclassifications</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Certain amounts recorded in the prior-period consolidated financial statements have been reclassified to conform to the current-period financial statement presentation. These reclassifications had no effect on previously reported results of operations.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p>
CY2024Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	18882906
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	18457912
CY2024Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	4325983
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	4492609
CY2024Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	94635445
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	108224069
CY2024Q3	us-gaap	Inventory Gross InventoryGross	117844334
CY2024Q2	us-gaap	Inventory Gross InventoryGross	131174590
CY2024Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2156689
CY2024Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2323689
CY2024Q3	us-gaap	Inventory Net InventoryNet	115687645
CY2024Q2	us-gaap	Inventory Net InventoryNet	128850901
CY2024Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	18882906
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	18457912
CY2024Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	4325983
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	4492609
CY2024Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	94635445
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	108224069
CY2024Q3	us-gaap	Inventory Gross InventoryGross	117844334
CY2024Q2	us-gaap	Inventory Gross InventoryGross	131174590
CY2024Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2156689
CY2024Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2323689
CY2024Q3	us-gaap	Inventory Net InventoryNet	115687645
CY2024Q2	us-gaap	Inventory Net InventoryNet	128850901
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-3289160
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	262099
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6119288
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6091288
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	8996
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6119288
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-3289160
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	262099
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6091288
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	8996
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6119288
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6100284
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.54
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.54
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	691331
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	602081
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	186000
CY2024Q3	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	71174
CY2023Q3	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	184817
CY2024Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	248321
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	530502
CY2024Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	120861
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	379493
CY2024Q3	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	1407512
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	1528156
CY2024Q3	us-gaap	Long Term Debt LongTermDebt	70743267
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	69583387
CY2024Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	67785664
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	66244227
CY2024Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2957603
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3339160
CY2024Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	4748442
CY2024Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	5361574
CY2024Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2087938
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2214127
CY2024Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2660504
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3147447
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	67375314
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1328185
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	834557
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.54
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	691331
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	602081
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	186000
CY2024Q3	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	71174
CY2023Q3	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	184817
CY2024Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	248321
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	530502
CY2024Q3	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	1407512
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	1528156
CY2024Q3	us-gaap	Long Term Debt LongTermDebt	70743267
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	69583387
CY2024Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	67785664
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	66244227
CY2024Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2957603
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3339160
CY2024Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	4748442
CY2024Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	5361574
CY2024Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2087938
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2214127
CY2024Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2660504
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3147447
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	67375314
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1328185
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	834557
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	673231
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	466736
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	65244
CY2024Q3	us-gaap	Long Term Debt LongTermDebt	70743267
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	673231
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	466736
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	65244
CY2024Q3	us-gaap	Long Term Debt LongTermDebt	70743267
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	802213
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-154135
CY2024Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.3226
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-1.4276
CY2024Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7302639
CY2024Q3	us-gaap	Cumulative Earnings Deficit CumulativeEarningsDeficit	14036000
CY2024Q3	us-gaap	Use Of Estimates UseOfEstimates	<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Management Estimates and Uncertainties </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">- </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates made in preparing the consolidated financial statements include depreciation and amortization periods, the allowance for credit losses, excess and obsolete reserves for inventory, deferred income, deferred taxes, uncertain tax positions, valuation allowance for deferred taxes and valuation of long-lived assets. Actual results could materially differ from these estimates.</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The potential impact of continued economic uncertainty due to persistent inflation and continuing global supply chain shortages and unpredictability may have a significant adverse impact on the timing of delivery of customer orders and the levels of future customer orders.</span></p>
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	802213
CY2024Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.3226
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-1.4276
CY2024Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7302639
CY2024Q3	us-gaap	Cumulative Earnings Deficit CumulativeEarningsDeficit	14036000
CY2024Q3	us-gaap	Use Of Estimates UseOfEstimates	<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Management Estimates and Uncertainties </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">- </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates made in preparing the consolidated financial statements include depreciation and amortization periods, the allowance for credit losses, excess and obsolete reserves for inventory, deferred income, deferred taxes, uncertain tax positions, valuation allowance for deferred taxes and valuation of long-lived assets. Actual results could materially differ from these estimates.</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The potential impact of continued economic uncertainty due to persistent inflation and continuing global supply chain shortages and unpredictability may have a significant adverse impact on the timing of delivery of customer orders and the levels of future customer orders.</span></p>
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	59466
CY2024Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	35732628
CY2024Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	32103451
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	7814
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	59466
CY2024Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	35732628
CY2024Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	32103451
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	7814
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	59466
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	35724814
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	32043985
CY2024Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	84776978
CY2023Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	98130356
CY2024Q3	us-gaap	Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized	0
CY2024Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	7814
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	59466
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	35724814
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	32043985
CY2024Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	84776978
CY2023Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	98130356
CY2024Q3	us-gaap	Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized	0
CY2024Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3111062
CY2023Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	8063197
CY2024Q3	sgma	Contract With Customer Liability Revenue Recognized Excluding Opening Balance ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance	2612539
CY2023Q3	sgma	Contract With Customer Liability Revenue Recognized Excluding Opening Balance ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance	4996715
CY2024Q3	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	2666475
CY2023Q3	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	2475787
CY2024Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3164998
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	5542269
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3111062
CY2023Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	8063197
CY2024Q3	sgma	Contract With Customer Liability Revenue Recognized Excluding Opening Balance ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance	2612539
CY2023Q3	sgma	Contract With Customer Liability Revenue Recognized Excluding Opening Balance ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance	4996715
CY2024Q3	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	2666475
CY2023Q3	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	2475787
CY2024Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3164998
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	5542269
CY2024Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7302639
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7585366
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7463301
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3171681
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2789107
CY2024Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7302639
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7585366
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7463301
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3171681
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2789107
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4693774
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4958247
CY2024Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	6784837
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	6959660
CY2024Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2087938
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2214127
CY2024Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2660504
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3147447
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4693774
CY2024Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	6784837
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	6959660
CY2024Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2087938
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2214127
CY2024Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2660504
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3147447
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	928834

CY2024Q3

dei

Amendment Flag

AmendmentFlag

false

CY2024Q3

dei

Current Fiscal Year End Date

CurrentFiscalYearEndDate

--04-30

CY2024Q3

dei

Document Fiscal Period Focus

DocumentFiscalPeriodFocus

Q1

CY2024Q3

dei

Document Fiscal Year Focus

DocumentFiscalYearFocus

2025

CY2024Q3

dei

Entity Central Index Key

EntityCentralIndexKey

0000915358

CY2024Q3

dei

Entity Current Reporting Status

EntityCurrentReportingStatus

Yes

CY2024Q3

dei

Entity Interactive Data Current

EntityInteractiveDataCurrent

Yes

CY2024Q3

sgma

Proceeds From Equipment Note

ProceedsFromEquipmentNote

CY2024Q3

sgma

Purchase Of Property Plant And Equipment Financed Under Capital Leases

PurchaseOfPropertyPlantAndEquipmentFinancedUnderCapitalLeases

CY2024Q2

us-gaap

Commitments And Contingencies

CommitmentsAndContingencies

CY2024Q3

us-gaap

Commitments And Contingencies

CommitmentsAndContingencies

CY2024Q3

us-gaap

Finance Lease Liability Payments Due After Year Five

FinanceLeaseLiabilityPaymentsDueAfterYearFive

CY2024Q3

us-gaap

Finance Lease Liability Payments Due Year Five

FinanceLeaseLiabilityPaymentsDueYearFive

CY2024Q3

us-gaap

Finance Lease Liability Payments Due Year Four

FinanceLeaseLiabilityPaymentsDueYearFour

CY2024Q3

us-gaap

Payments Of Debt Issuance Costs

PaymentsOfDebtIssuanceCosts

CY2024Q2

us-gaap

Preferred Stock Value

PreferredStockValue

CY2024Q3

us-gaap

Preferred Stock Value

PreferredStockValue

CY2023Q3

us-gaap

Provision For Loan Lease And Other Losses

ProvisionForLoanLeaseAndOtherLosses

CY2024Q3

us-gaap

Right Of Use Asset Obtained In Exchange For Finance Lease Liability

RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability

CY2024Q3

dei

Document Type

DocumentType

10-Q

CY2024Q3

dei

Document Quarterly Report

DocumentQuarterlyReport

true

CY2024Q3

dei

Document Period End Date

DocumentPeriodEndDate

2024-07-31

CY2024Q3

dei

Document Transition Report

DocumentTransitionReport

false

CY2024Q3

dei

Entity File Number

EntityFileNumber

0-23248

CY2024Q3

dei

Entity Registrant Name

EntityRegistrantName

SIGMATRON INTERNATIONAL, INC.

CY2024Q3

dei

Entity Incorporation State Country Code

EntityIncorporationStateCountryCode

DE

CY2023Q3

us-gaap

Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value

AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue

184817

CY2023Q3

us-gaap

Net Income Loss

NetIncomeLoss

262099

CY2023Q3

us-gaap

Stockholders Equity

StockholdersEquity

68537943

CY2024Q3

us-gaap

Net Income Loss

NetIncomeLoss

-3289160

CY2024Q3

dei

Entity Tax Identification Number

EntityTaxIdentificationNumber

36-3918470

CY2024Q3

dei

Entity Address Address Line1

EntityAddressAddressLine1

2201 Landmeier Road

CY2024Q3

dei

Entity Address City Or Town

EntityAddressCityOrTown

Elk Grove Village

CY2024Q3

dei

Entity Address State Or Province

EntityAddressStateOrProvince

IL

CY2024Q3

dei

Entity Address Postal Zip Code

EntityAddressPostalZipCode

60007

CY2024Q3

dei

City Area Code

CityAreaCode

847

CY2024Q3

dei

Local Phone Number

LocalPhoneNumber

956-8000

CY2024Q3

dei

Security12b Title

Security12bTitle

Common Stock $0.01 par value per share

CY2024Q3

dei

Trading Symbol

TradingSymbol

SGMA

CY2024Q3

dei

Security Exchange Name

SecurityExchangeName

NASDAQ

CY2024Q3

dei

Entity Filer Category

EntityFilerCategory

Non-accelerated Filer

CY2024Q3

dei

Entity Small Business

EntitySmallBusiness

true

CY2024Q3

dei

Entity Emerging Growth Company

EntityEmergingGrowthCompany

false

CY2024Q3

dei

Entity Shell Company

EntityShellCompany

false

CY2024Q3

dei

Entity Common Stock Shares Outstanding

EntityCommonStockSharesOutstanding

6119288

CY2024Q3

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

5303318

CY2024Q2

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

2417360

CY2024Q3

us-gaap

Allowance For Doubtful Accounts Receivable Current

AllowanceForDoubtfulAccountsReceivableCurrent

7814

CY2024Q2

us-gaap

Allowance For Doubtful Accounts Receivable Current

AllowanceForDoubtfulAccountsReceivableCurrent

59466

CY2024Q3

us-gaap

Accounts Receivable Net Current

AccountsReceivableNetCurrent

35724814

CY2024Q2

us-gaap

Accounts Receivable Net Current

AccountsReceivableNetCurrent

32043985

CY2024Q3

us-gaap

Inventory Net

InventoryNet

115687645

CY2024Q2

us-gaap

Inventory Net

InventoryNet

128850901

CY2024Q3

us-gaap

Prepaid Expense And Other Assets Current

PrepaidExpenseAndOtherAssetsCurrent

1674022

CY2024Q2

us-gaap

Prepaid Expense And Other Assets Current

PrepaidExpenseAndOtherAssetsCurrent

1886701

CY2024Q3

us-gaap

Income Taxes Receivable

IncomeTaxesReceivable

771535

CY2024Q2

us-gaap

Income Taxes Receivable

IncomeTaxesReceivable

1716372

CY2024Q3

us-gaap

Value Added Tax Receivable Current

ValueAddedTaxReceivableCurrent

6211685

CY2024Q2

us-gaap

Value Added Tax Receivable Current

ValueAddedTaxReceivableCurrent

6569984

CY2024Q3

us-gaap

Other Receivables Net Current

OtherReceivablesNetCurrent

2521174

CY2024Q2

us-gaap

Other Receivables Net Current

OtherReceivablesNetCurrent

2417316

CY2024Q3

us-gaap

Assets Current

AssetsCurrent

167894193

CY2024Q2

us-gaap

Assets Current

AssetsCurrent

175902619

CY2024Q3

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

32497960

CY2024Q2

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

33755078

CY2024Q3

us-gaap

Finite Lived Intangible Assets Net

FiniteLivedIntangibleAssetsNet

897567

CY2024Q2

us-gaap

Finite Lived Intangible Assets Net

FiniteLivedIntangibleAssetsNet

979188

CY2024Q3

us-gaap

Deferred Income Tax Assets Net

DeferredIncomeTaxAssetsNet

8752870

CY2024Q2

us-gaap

Deferred Income Tax Assets Net

DeferredIncomeTaxAssetsNet

4432210

CY2024Q3

us-gaap

Operating Lease Right Of Use Asset

OperatingLeaseRightOfUseAsset

7585366

CY2024Q2

us-gaap

Operating Lease Right Of Use Asset

OperatingLeaseRightOfUseAsset

7463301

CY2024Q3

us-gaap

Other Assets Noncurrent

OtherAssetsNoncurrent

1213762

CY2024Q2

us-gaap

Other Assets Noncurrent

OtherAssetsNoncurrent

1261579

CY2024Q3

sgma

Other Long Term Assets

OtherLongTermAssets

18449565

CY2024Q2

sgma

Other Long Term Assets

OtherLongTermAssets

14136278

CY2024Q3

us-gaap

Assets

218841718

CY2024Q2

us-gaap

Assets

223793975

CY2024Q3

us-gaap

Accounts Payable Trade Current

AccountsPayableTradeCurrent

46621825

CY2024Q2

us-gaap

Accounts Payable Trade Current

AccountsPayableTradeCurrent

50593099

CY2024Q3

sgma

Customer Deposit Current

CustomerDepositCurrent

9182867

CY2024Q2

sgma

Customer Deposit Current

CustomerDepositCurrent

10738596

CY2024Q3

us-gaap

Employee Related Liabilities Current

EmployeeRelatedLiabilitiesCurrent

6276555

CY2024Q2

us-gaap

Employee Related Liabilities Current

EmployeeRelatedLiabilitiesCurrent

6746466

CY2024Q3

us-gaap

Accrued Liabilities Current

AccruedLiabilitiesCurrent

2143130

CY2024Q2

us-gaap

Accrued Liabilities Current

AccruedLiabilitiesCurrent

2554260

CY2024Q3

us-gaap

Accrued Income Taxes Current

AccruedIncomeTaxesCurrent

4981747

CY2024Q2

us-gaap

Accrued Income Taxes Current

AccruedIncomeTaxesCurrent

897847

CY2024Q3

us-gaap

Deferred Income

DeferredIncome

3164998

CY2024Q2

us-gaap

Deferred Income

DeferredIncome

3111062

CY2024Q3

us-gaap

Long Term Debt Current

LongTermDebtCurrent

67785664

CY2024Q2

us-gaap

Long Term Debt Current

LongTermDebtCurrent

66244227

CY2024Q3

us-gaap

Finance Lease Liability Current

FinanceLeaseLiabilityCurrent

2087938

CY2024Q2

us-gaap

Finance Lease Liability Current

FinanceLeaseLiabilityCurrent

2214127

CY2024Q3

us-gaap

Operating Lease Liability Current

OperatingLeaseLiabilityCurrent

3171681

CY2024Q2

us-gaap

Operating Lease Liability Current

OperatingLeaseLiabilityCurrent

2789107

CY2024Q3

us-gaap

Liabilities Current

LiabilitiesCurrent

145416405

CY2024Q2

us-gaap

Liabilities Current

LiabilitiesCurrent

145888791

CY2024Q3

us-gaap

Long Term Debt Noncurrent

LongTermDebtNoncurrent

2957603

CY2024Q2

us-gaap

Long Term Debt Noncurrent

LongTermDebtNoncurrent

3339160

CY2024Q3

us-gaap

Accrued Income Taxes Noncurrent

AccruedIncomeTaxesNoncurrent

153983

CY2024Q2

us-gaap

Accrued Income Taxes Noncurrent

AccruedIncomeTaxesNoncurrent

294993

CY2024Q3

us-gaap

Finance Lease Liability Noncurrent

FinanceLeaseLiabilityNoncurrent

2660504

CY2024Q2

us-gaap

Finance Lease Liability Noncurrent

FinanceLeaseLiabilityNoncurrent

3147447

CY2024Q3

us-gaap

Operating Lease Liability Noncurrent

OperatingLeaseLiabilityNoncurrent

4693774

CY2024Q2

us-gaap

Operating Lease Liability Noncurrent

OperatingLeaseLiabilityNoncurrent

4958247

CY2024Q3

us-gaap

Other Liabilities Noncurrent

OtherLiabilitiesNoncurrent

105182

CY2024Q2

us-gaap

Other Liabilities Noncurrent

OtherLiabilitiesNoncurrent

93084

CY2024Q3

us-gaap

Liabilities Noncurrent

LiabilitiesNoncurrent

10571046

CY2024Q2

us-gaap

Liabilities Noncurrent

LiabilitiesNoncurrent

11832931

CY2024Q3

us-gaap

Liabilities

155987451

CY2024Q2

us-gaap

Liabilities

157721722

CY2024Q2

us-gaap

Preferred Stock Par Or Stated Value Per Share

PreferredStockParOrStatedValuePerShare

0.01

CY2024Q3

us-gaap

Preferred Stock Par Or Stated Value Per Share

PreferredStockParOrStatedValuePerShare

0.01

CY2024Q2

us-gaap

Preferred Stock Shares Authorized

PreferredStockSharesAuthorized

500000

CY2024Q3

us-gaap

Preferred Stock Shares Authorized

PreferredStockSharesAuthorized

500000

CY2024Q2

us-gaap

Preferred Stock Shares Issued

PreferredStockSharesIssued

0

CY2024Q3

us-gaap

Preferred Stock Shares Issued

PreferredStockSharesIssued

0

CY2024Q2

us-gaap

Preferred Stock Shares Outstanding

PreferredStockSharesOutstanding

0

CY2024Q3

us-gaap

Preferred Stock Shares Outstanding

PreferredStockSharesOutstanding

0

CY2024Q2

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.01

CY2024Q3

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.01

CY2024Q2

us-gaap

Common Stock Shares Authorized

CommonStockSharesAuthorized

12000000

CY2024Q3

us-gaap

Common Stock Shares Authorized

CommonStockSharesAuthorized

12000000

CY2024Q2

us-gaap

Common Stock Shares Issued

CommonStockSharesIssued

6119288

CY2024Q3

us-gaap

Common Stock Shares Issued

CommonStockSharesIssued

6119288

CY2024Q2

us-gaap

Common Stock Shares Outstanding

CommonStockSharesOutstanding

6119288

CY2024Q3

us-gaap

Common Stock Shares Outstanding

CommonStockSharesOutstanding

6119288

CY2024Q3

us-gaap

Common Stock Value

CommonStockValue

61193

CY2024Q2

us-gaap

Common Stock Value

CommonStockValue

61193

CY2024Q3

us-gaap

Additional Paid In Capital Common Stock

AdditionalPaidInCapitalCommonStock

42524568

CY2024Q2

us-gaap

Additional Paid In Capital Common Stock

AdditionalPaidInCapitalCommonStock

42453394

CY2024Q3

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

20268506

CY2024Q2

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

23557666

CY2024Q3

us-gaap

Stockholders Equity

StockholdersEquity

62854267

CY2024Q2

us-gaap

Stockholders Equity

StockholdersEquity

66072253

CY2024Q3

us-gaap

Liabilities And Stockholders Equity

LiabilitiesAndStockholdersEquity

218841718

CY2024Q2

us-gaap

Liabilities And Stockholders Equity

LiabilitiesAndStockholdersEquity

223793975

CY2024Q3

us-gaap

Revenue From Contract With Customer Including Assessed Tax

RevenueFromContractWithCustomerIncludingAssessedTax

84776978

CY2023Q3

us-gaap

Revenue From Contract With Customer Including Assessed Tax

RevenueFromContractWithCustomerIncludingAssessedTax

98130356

CY2024Q3

us-gaap

Cost Of Goods And Services Sold

CostOfGoodsAndServicesSold

78371784

CY2023Q3

us-gaap

Cost Of Goods And Services Sold

CostOfGoodsAndServicesSold

88479136

CY2024Q3

us-gaap

Gross Profit

GrossProfit

6405194

CY2023Q3

us-gaap

Gross Profit

GrossProfit

9651220

CY2024Q3

us-gaap

Selling General And Administrative Expense

SellingGeneralAndAdministrativeExpense

6623866

CY2023Q3

us-gaap

Selling General And Administrative Expense

SellingGeneralAndAdministrativeExpense

6842805

CY2024Q3

us-gaap

Operating Income Loss

OperatingIncomeLoss

-218672

CY2023Q3

us-gaap

Operating Income Loss

OperatingIncomeLoss

2808415

CY2023Q3

us-gaap

Nonoperating Income Expense

NonoperatingIncomeExpense

18627

CY2024Q3

us-gaap

Interest Expense

InterestExpense

2268275

CY2023Q3

us-gaap

Interest Expense

InterestExpense

2719078

CY2024Q3

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

-2486947

CY2023Q3

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

107964

CY2024Q3

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

802213

CY2023Q3

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

-154135

CY2024Q3

us-gaap

Net Income Loss

NetIncomeLoss

-3289160

CY2023Q3

us-gaap

Net Income Loss

NetIncomeLoss

262099

CY2024Q3

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

-0.54

CY2023Q3

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.04

CY2024Q3

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

-0.54

CY2023Q3

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.04

CY2024Q3

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

6119288

CY2023Q3

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

6091288

CY2024Q3

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

6119288

CY2023Q3

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

6100284

CY2024Q2

us-gaap

Stockholders Equity

StockholdersEquity

66072253

CY2024Q3

us-gaap

Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value

AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue

71174

CY2024Q3

us-gaap

Net Income Loss

NetIncomeLoss

-3289160

CY2024Q3

us-gaap

Stockholders Equity

StockholdersEquity

62854267

CY2023Q2

us-gaap

Stockholders Equity

StockholdersEquity

68091027

CY2023Q3

us-gaap

Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value

AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue

184817

CY2023Q3

us-gaap

Net Income Loss

NetIncomeLoss

262099

CY2023Q3

us-gaap

Stockholders Equity

StockholdersEquity

68537943

CY2024Q3

us-gaap

Net Income Loss

NetIncomeLoss

-3289160

CY2023Q3

us-gaap

Net Income Loss

NetIncomeLoss

262099

CY2024Q3

sgma

Depreciation And Amortization Expense

DepreciationAndAmortizationExpense

1424092

CY2023Q3

sgma

Depreciation And Amortization Expense

DepreciationAndAmortizationExpense

1496034

CY2024Q3

us-gaap

Allocated Share Based Compensation Expense

AllocatedShareBasedCompensationExpense

71174

CY2023Q3

us-gaap

Allocated Share Based Compensation Expense

AllocatedShareBasedCompensationExpense

184817

CY2024Q3

us-gaap

Provision For Loan Lease And Other Losses

ProvisionForLoanLeaseAndOtherLosses

51652

CY2024Q3

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

-4320660

CY2023Q3

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

180213

CY2024Q3

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

81621

CY2023Q3

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

83415

CY2024Q3

us-gaap

Amortization Of Financing Costs

AmortizationOfFinancingCosts

120644

CY2023Q3

us-gaap

Amortization Of Financing Costs

AmortizationOfFinancingCosts

116745

CY2024Q3

us-gaap

Gain Loss On Sale Of Property Plant Equipment

GainLossOnSaleOfPropertyPlantEquipment

-839

CY2023Q3

us-gaap

Gain Loss On Sale Of Property Plant Equipment

GainLossOnSaleOfPropertyPlantEquipment

-43286

CY2024Q3

us-gaap

Increase Decrease In Accounts Receivable

IncreaseDecreaseInAccountsReceivable

3732481

CY2023Q3

us-gaap

Increase Decrease In Accounts Receivable

IncreaseDecreaseInAccountsReceivable

-2058165

CY2024Q3

us-gaap

Increase Decrease In Inventories

IncreaseDecreaseInInventories

-13163256

CY2023Q3

us-gaap

Increase Decrease In Inventories

IncreaseDecreaseInInventories

-7092926

CY2024Q3

us-gaap

Increase Decrease In Prepaid Deferred Expense And Other Assets

IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

-632335

CY2023Q3

us-gaap

Increase Decrease In Prepaid Deferred Expense And Other Assets

IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

611805

CY2024Q3

sgma

Increase Decrease In Right Of Use Assets

IncreaseDecreaseInRightOfUseAssets

122065

CY2023Q3

sgma

Increase Decrease In Right Of Use Assets

IncreaseDecreaseInRightOfUseAssets

-801201

CY2024Q3

us-gaap

Increase Decrease In Income Taxes Receivable

IncreaseDecreaseInIncomeTaxesReceivable

-944837

CY2023Q3

us-gaap

Increase Decrease In Income Taxes Receivable

IncreaseDecreaseInIncomeTaxesReceivable

-368218

CY2024Q3

us-gaap

Increase Decrease In Accrued Income Taxes Payable

IncreaseDecreaseInAccruedIncomeTaxesPayable

3942890

CY2023Q3

us-gaap

Increase Decrease In Accrued Income Taxes Payable

IncreaseDecreaseInAccruedIncomeTaxesPayable

-1161108

CY2024Q3

us-gaap

Increase Decrease In Accounts Payable Trade

IncreaseDecreaseInAccountsPayableTrade

-3971274

CY2023Q3

us-gaap

Increase Decrease In Accounts Payable Trade

IncreaseDecreaseInAccountsPayableTrade

-10241474

CY2024Q3

sgma

Increase Decrease In Customer Deposit

IncreaseDecreaseInCustomerDeposit

-1555729

CY2023Q3

sgma

Increase Decrease In Customer Deposit

IncreaseDecreaseInCustomerDeposit

9717955

CY2024Q3

sgma

Increase Decrease In Operating Lease Liabilities

IncreaseDecreaseInOperatingLeaseLiabilities

-118101

CY2023Q3

sgma

Increase Decrease In Operating Lease Liabilities

IncreaseDecreaseInOperatingLeaseLiabilities

779898

CY2024Q3

us-gaap

Increase Decrease In Accounts Payable And Accrued Liabilities

IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

-986341

CY2023Q3

us-gaap

Increase Decrease In Accounts Payable And Accrued Liabilities

IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

660153

CY2024Q3

us-gaap

Increase Decrease In Deferred Revenue

IncreaseDecreaseInDeferredRevenue

53936

CY2023Q3

us-gaap

Increase Decrease In Deferred Revenue

IncreaseDecreaseInDeferredRevenue

-2520928

CY2023Q3

us-gaap

Net Income Loss

NetIncomeLoss

262099

CY2024Q3

us-gaap

Allocated Share Based Compensation Expense

AllocatedShareBasedCompensationExpense

71174

CY2023Q3

us-gaap

Allocated Share Based Compensation Expense

AllocatedShareBasedCompensationExpense

184817

CY2024Q3

us-gaap

Provision For Loan Lease And Other Losses

ProvisionForLoanLeaseAndOtherLosses

51652

CY2024Q3

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

-4320660

CY2023Q3

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

180213

CY2024Q3

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

81621

CY2023Q3

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

83415

CY2024Q3

us-gaap

Amortization Of Financing Costs

AmortizationOfFinancingCosts

120644

CY2023Q3

us-gaap

Amortization Of Financing Costs

AmortizationOfFinancingCosts

116745

CY2024Q3

us-gaap

Gain Loss On Sale Of Property Plant Equipment

GainLossOnSaleOfPropertyPlantEquipment

-839

CY2023Q3

us-gaap

Gain Loss On Sale Of Property Plant Equipment

GainLossOnSaleOfPropertyPlantEquipment

-43286

CY2024Q3

us-gaap

Increase Decrease In Accounts Receivable

IncreaseDecreaseInAccountsReceivable

3732481

CY2023Q3

us-gaap

Increase Decrease In Accounts Receivable

IncreaseDecreaseInAccountsReceivable

-2058165

CY2024Q3

us-gaap

Increase Decrease In Inventories

IncreaseDecreaseInInventories

-13163256

CY2023Q3

us-gaap

Increase Decrease In Inventories

IncreaseDecreaseInInventories

-7092926

CY2024Q3

us-gaap

Increase Decrease In Prepaid Deferred Expense And Other Assets

IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

-632335

CY2023Q3

us-gaap

Increase Decrease In Prepaid Deferred Expense And Other Assets

IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

611805

CY2024Q3

sgma

Increase Decrease In Right Of Use Assets

IncreaseDecreaseInRightOfUseAssets

122065

CY2023Q3

sgma

Increase Decrease In Right Of Use Assets

IncreaseDecreaseInRightOfUseAssets

-801201

CY2024Q3

us-gaap

Increase Decrease In Income Taxes Receivable

IncreaseDecreaseInIncomeTaxesReceivable

-944837

CY2023Q3

us-gaap

Increase Decrease In Income Taxes Receivable

IncreaseDecreaseInIncomeTaxesReceivable

-368218

CY2024Q3

us-gaap

Increase Decrease In Accrued Income Taxes Payable

IncreaseDecreaseInAccruedIncomeTaxesPayable

3942890

CY2023Q3

us-gaap

Increase Decrease In Accrued Income Taxes Payable

IncreaseDecreaseInAccruedIncomeTaxesPayable

-1161108

CY2024Q3

us-gaap

Increase Decrease In Accounts Payable Trade

IncreaseDecreaseInAccountsPayableTrade

-3971274

CY2023Q3

us-gaap

Increase Decrease In Accounts Payable Trade

IncreaseDecreaseInAccountsPayableTrade

-10241474

CY2024Q3

sgma

Increase Decrease In Customer Deposit

IncreaseDecreaseInCustomerDeposit

-1555729

CY2023Q3

sgma

Increase Decrease In Customer Deposit

IncreaseDecreaseInCustomerDeposit

9717955

CY2024Q3

sgma

Increase Decrease In Operating Lease Liabilities

IncreaseDecreaseInOperatingLeaseLiabilities

-118101

CY2023Q3

sgma

Increase Decrease In Operating Lease Liabilities

IncreaseDecreaseInOperatingLeaseLiabilities

779898

CY2024Q3

us-gaap

Increase Decrease In Accounts Payable And Accrued Liabilities

IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

-986341

CY2023Q3

us-gaap

Increase Decrease In Accounts Payable And Accrued Liabilities

IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

660153

CY2024Q3

us-gaap

Increase Decrease In Deferred Revenue

IncreaseDecreaseInDeferredRevenue

53936

CY2023Q3

us-gaap

Increase Decrease In Deferred Revenue

IncreaseDecreaseInDeferredRevenue

-2520928

CY2024Q3

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

2627667

CY2023Q3

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

7750014

CY2024Q3

us-gaap

Payments To Acquire Machinery And Equipment

PaymentsToAcquireMachineryAndEquipment

167813

CY2023Q3

us-gaap

Payments To Acquire Machinery And Equipment

PaymentsToAcquireMachineryAndEquipment

621929

CY2024Q3

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-167813

CY2023Q3

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-621929

CY2023Q3

sgma

Proceeds From Equipment Note

ProceedsFromEquipmentNote

783461

CY2024Q3

us-gaap

Finance Lease Principal Payments

FinanceLeasePrincipalPayments

613132

CY2023Q3

us-gaap

Finance Lease Principal Payments

FinanceLeasePrincipalPayments

428105

CY2024Q3

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

2627667

CY2023Q3

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

7750014

CY2024Q3

us-gaap

Payments To Acquire Machinery And Equipment

PaymentsToAcquireMachineryAndEquipment

167813

CY2023Q3

us-gaap

Payments To Acquire Machinery And Equipment

PaymentsToAcquireMachineryAndEquipment

621929

CY2024Q3

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-167813

CY2023Q3

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-621929

CY2023Q3

sgma

Proceeds From Equipment Note

ProceedsFromEquipmentNote

783461

CY2024Q3

us-gaap

Finance Lease Principal Payments

FinanceLeasePrincipalPayments

613132

CY2023Q3

us-gaap

Finance Lease Principal Payments

FinanceLeasePrincipalPayments

428105

CY2024Q3

sgma

Repayments Of Equipment Note

RepaymentsOfEquipmentNote

383600

CY2023Q3

sgma

Repayments Of Equipment Note

RepaymentsOfEquipmentNote

278250

CY2024Q3

us-gaap

Repayments Of Notes Payable

RepaymentsOfNotesPayable

13103

CY2023Q3

us-gaap

Repayments Of Notes Payable

RepaymentsOfNotesPayable

12372

CY2024Q3

us-gaap

Repayments Of Secured Debt

RepaymentsOfSecuredDebt

250000

CY2023Q3

us-gaap

Repayments Of Secured Debt

RepaymentsOfSecuredDebt

250000

CY2024Q3

us-gaap

Proceeds From Lines Of Credit

ProceedsFromLinesOfCredit

87317346

CY2023Q3

us-gaap

Proceeds From Lines Of Credit

ProceedsFromLinesOfCredit

103905204

CY2024Q3

us-gaap

Repayments Of Lines Of Credit

RepaymentsOfLinesOfCredit

85631407

CY2023Q3

us-gaap

Repayments Of Lines Of Credit

RepaymentsOfLinesOfCredit

109632319

CY2023Q3

us-gaap

Payments Of Debt Issuance Costs

PaymentsOfDebtIssuanceCosts

379942

CY2024Q3

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

426104

CY2023Q3

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

-6292323

CY2024Q3

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect

2885958

CY2023Q3

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect

835762

CY2024Q2

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

2417360

CY2023Q2

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

819129

CY2024Q3

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

5303318

CY2023Q3

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

1654891

CY2024Q3

us-gaap

Interest Paid Net

InterestPaidNet

2217494

CY2023Q3

us-gaap

Interest Paid Net

InterestPaidNet

2583509

CY2024Q3

us-gaap

Income Taxes Paid Net

IncomeTaxesPaidNet

383245

CY2023Q3

us-gaap

Income Taxes Paid Net

IncomeTaxesPaidNet

434038

CY2023Q3

sgma

Purchase Of Property Plant And Equipment Financed Under Capital Leases

PurchaseOfPropertyPlantAndEquipmentFinancedUnderCapitalLeases

1032351

CY2024Q3

us-gaap

Right Of Use Asset Obtained In Exchange For Operating Lease Liability

RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability

936399

CY2023Q3

us-gaap

Right Of Use Asset Obtained In Exchange For Operating Lease Liability

RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability

1531

CY2024Q3

us-gaap

Nature Of Operations

NatureOfOperations

Note A - Description of the Business SigmaTron International, Inc., its subsidiaries, foreign enterprises and international procurement office (collectively, “SigmaTron” or the “Company”) operates in one reportable segment as an independent provider of electronic manufacturing services (“EMS”). EMS includes printed circuit board assemblies, electro-mechanical subassemblies and completely assembled (box-build) electronic products. In connection with the production of assembled products, EMS also provides services to its customers, including (1) automatic and manual assembly and testing of products; (2) material sourcing and procurement; (3) manufacturing and test engineering support; (4) design services; (5) warehousing and distribution services; (6) assistance in obtaining product approval from governmental and other regulatory bodies and (7) compliance reporting. The Company’s primary secured credit agreements, being the Amended and Restated Credit Agreement dated as of July 18, 2022 (as amended, restated, supplemented or otherwise modified from time to time, the “JPM Credit Agreement”) by and among the Company, the other loan party thereto and JPMorgan Chase Bank, N.A, as lender (“JPM”), and the Credit Agreement dated as of July 18, 2022 (as amended, restated, supplemented or otherwise modified from time to time, the “Term Loan Agreement” and together with the JPM Credit Agreement, the “Credit Agreements”) by and among the Company, the financial institutions identified therein (the “TCW Lenders”) and TCW Asset Management Company LLC, as administrative agent for the TCW Lenders (in such capacity, the “Agent,” and collectively with the TCW Lenders and JPM, the “Lender Parties”), contain financial covenants relating to (i) the Fixed Charge Coverage Ratio (as defined in the Credit Agreements), which is the ratio of the Company’s fixed payments on its indebtedness made during any fiscal period minus non-financed capital expenditures to EBITDA (as defined in the Credit Agreements) and (ii) the Total Debt to EBITDA Ratio (as defined in the Credit Agreements), which is the ratio of the Company’s borrowed money or letters of credit to EBITDA. As of August 19, 2024, the Company was not in compliance with the financial covenants under the Credit Agreements as follows: the Fixed Charge Coverage Ratio for each of the twelve month periods ending on April 30, 2024, May 31, 2024, June 30, 2024, and July 31, 2024 was less than 1.10:1.00, the Total Debt to EBITDA Ratio for the twelve month period ending on April 30, 2024 was greater than 4.50:1.00, and the Total Debt to EBITDA Ratio for the twelve month period ending on July 31, 2024 was greater than 4.25:1.00 (collectively, the “2024 Covenant Defaults”). In addition, the Company received a delinquency notification letter from Nasdaq, dated August 16, 2024, indicating that the Company was not in compliance with the continued listing requirements of Nasdaq for failing to timely file the Company’s Form 10- K annual report for the fiscal year ended April 30, 2024. This notification also constituted a default under the Credit Agreements (collectively with the 2024 Covenant Defaults, the “2024 Defaults”). The Company had 60 days from the date of the Nasdaq delinquency notice, or until October 15, 2024, to file a plan with Nasdaq to regain compliance. On September 10, 2024, the Company received a notification letter from Nasdaq indicating that the Company had regained compliance with the applicable continued listing requirements based on the filing of the Company’s Form 10-K annual report for the fiscal year ended April 30, 2024. Due to the Covenant Defaults, the facilities under the Credit Agreements were classified as current liabilities on the Consolidated Balance Sheet at July 31, 2024 and April 30, 2024. On August 19, 2024 (the “Third Amendment Effective Date”), the Lender Parties waived the 2024 Defaults pursuant to (i) the Waiver and Amendment No. 3 to Credit Agreement (the “JPM Amendment”) between the Company and JPM, and (ii) the Waiver and Amendment No. 3 to Credit <h1 dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;">Note A - Description of the Business - Continued</h1> Agreement (the “TCW Amendment” and together with the JPM Amendment, the “2024 Amendments”) by and among the Company, the TCW Lenders, and the Agent. In consideration of the TCW Amendment, the Company and the Agent also entered into the Third Amendment Fee Letter to the TCW Credit Agreement (the “Fee Letter”) dated as of the Third Amendment Effective Date. The 2024 Amendments also amended the financial covenants and certain other terms of the Credit Agreements, including, among other things, that the Company will pursue and close a Replacement Transaction (as defined in the Credit Agreements) to pay the obligations under the Credit Agreements in full no later than September 30, 2025 unless the Company meets certain debt ratios for the twelve month period ending on August 31, 2025. See Waivers and Amendments No. 3 within Note E – Long-term Debt for more information. The Company is taking steps to reduce its debt and cost structure. Most recently, since the beginning of calendar year 2024, these actions include the sale of its Elgin, Illinois property and consolidation of the Elgin operations to the Elk Grove Village, Illinois headquarters, reduction of headcounts at various operations and corporate, and inventory reduction. At this time, it is expected that these results plus the amendments to the financial covenants and other provisions of the Credit Agreements that are included in the 2024 Amendments should poise the Company for compliance. At the same time, the Company continues to explore other strategic initiatives to further reduce its debt to enable it to continue to comply with increasingly stringent financial covenants. Delays or a failure to effectively reduce debt, including due to circumstances outside of our control, could have an adverse effect on our financial position and results of operations.

CY2024Q3

us-gaap

Number Of Reportable Segments

NumberOfReportableSegments

1

CY2024Q3

sgma

Repayments Of Equipment Note

RepaymentsOfEquipmentNote

383600

CY2023Q3

sgma

Repayments Of Equipment Note

RepaymentsOfEquipmentNote

278250

CY2024Q3

us-gaap

Repayments Of Notes Payable

RepaymentsOfNotesPayable

13103

CY2023Q3

us-gaap

Repayments Of Notes Payable

RepaymentsOfNotesPayable

12372

CY2024Q3

us-gaap

Repayments Of Secured Debt

RepaymentsOfSecuredDebt

250000

CY2023Q3

us-gaap

Repayments Of Secured Debt

RepaymentsOfSecuredDebt

250000

CY2024Q3

us-gaap

Proceeds From Lines Of Credit

ProceedsFromLinesOfCredit

87317346

CY2023Q3

us-gaap

Proceeds From Lines Of Credit

ProceedsFromLinesOfCredit

103905204

CY2024Q3

us-gaap

Repayments Of Lines Of Credit

RepaymentsOfLinesOfCredit

85631407

CY2023Q3

us-gaap

Repayments Of Lines Of Credit

RepaymentsOfLinesOfCredit

109632319

CY2023Q3

us-gaap

Payments Of Debt Issuance Costs

PaymentsOfDebtIssuanceCosts

379942

CY2024Q3

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

426104

CY2023Q3

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

-6292323

CY2024Q3

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect

2885958

CY2023Q3

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect

835762

CY2024Q2

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

2417360

CY2023Q2

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

819129

CY2024Q3

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

5303318

CY2023Q3

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

1654891

CY2024Q3

us-gaap

Interest Paid Net

InterestPaidNet

2217494

CY2023Q3

us-gaap

Interest Paid Net

InterestPaidNet

2583509

CY2024Q3

us-gaap

Income Taxes Paid Net

IncomeTaxesPaidNet

383245

CY2023Q3

us-gaap

Income Taxes Paid Net

IncomeTaxesPaidNet

434038

CY2023Q3

sgma

Purchase Of Property Plant And Equipment Financed Under Capital Leases

PurchaseOfPropertyPlantAndEquipmentFinancedUnderCapitalLeases

1032351

CY2024Q3

us-gaap

Right Of Use Asset Obtained In Exchange For Operating Lease Liability

RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability

936399

CY2023Q3

us-gaap

Right Of Use Asset Obtained In Exchange For Operating Lease Liability

RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability

1531

CY2024Q3

us-gaap

Nature Of Operations

NatureOfOperations

Note A - Description of the Business SigmaTron International, Inc., its subsidiaries, foreign enterprises and international procurement office (collectively, “SigmaTron” or the “Company”) operates in one reportable segment as an independent provider of electronic manufacturing services (“EMS”). EMS includes printed circuit board assemblies, electro-mechanical subassemblies and completely assembled (box-build) electronic products. In connection with the production of assembled products, EMS also provides services to its customers, including (1) automatic and manual assembly and testing of products; (2) material sourcing and procurement; (3) manufacturing and test engineering support; (4) design services; (5) warehousing and distribution services; (6) assistance in obtaining product approval from governmental and other regulatory bodies and (7) compliance reporting. The Company’s primary secured credit agreements, being the Amended and Restated Credit Agreement dated as of July 18, 2022 (as amended, restated, supplemented or otherwise modified from time to time, the “JPM Credit Agreement”) by and among the Company, the other loan party thereto and JPMorgan Chase Bank, N.A, as lender (“JPM”), and the Credit Agreement dated as of July 18, 2022 (as amended, restated, supplemented or otherwise modified from time to time, the “Term Loan Agreement” and together with the JPM Credit Agreement, the “Credit Agreements”) by and among the Company, the financial institutions identified therein (the “TCW Lenders”) and TCW Asset Management Company LLC, as administrative agent for the TCW Lenders (in such capacity, the “Agent,” and collectively with the TCW Lenders and JPM, the “Lender Parties”), contain financial covenants relating to (i) the Fixed Charge Coverage Ratio (as defined in the Credit Agreements), which is the ratio of the Company’s fixed payments on its indebtedness made during any fiscal period minus non-financed capital expenditures to EBITDA (as defined in the Credit Agreements) and (ii) the Total Debt to EBITDA Ratio (as defined in the Credit Agreements), which is the ratio of the Company’s borrowed money or letters of credit to EBITDA. As of August 19, 2024, the Company was not in compliance with the financial covenants under the Credit Agreements as follows: the Fixed Charge Coverage Ratio for each of the twelve month periods ending on April 30, 2024, May 31, 2024, June 30, 2024, and July 31, 2024 was less than 1.10:1.00, the Total Debt to EBITDA Ratio for the twelve month period ending on April 30, 2024 was greater than 4.50:1.00, and the Total Debt to EBITDA Ratio for the twelve month period ending on July 31, 2024 was greater than 4.25:1.00 (collectively, the “2024 Covenant Defaults”). In addition, the Company received a delinquency notification letter from Nasdaq, dated August 16, 2024, indicating that the Company was not in compliance with the continued listing requirements of Nasdaq for failing to timely file the Company’s Form 10- K annual report for the fiscal year ended April 30, 2024. This notification also constituted a default under the Credit Agreements (collectively with the 2024 Covenant Defaults, the “2024 Defaults”). The Company had 60 days from the date of the Nasdaq delinquency notice, or until October 15, 2024, to file a plan with Nasdaq to regain compliance. On September 10, 2024, the Company received a notification letter from Nasdaq indicating that the Company had regained compliance with the applicable continued listing requirements based on the filing of the Company’s Form 10-K annual report for the fiscal year ended April 30, 2024. Due to the Covenant Defaults, the facilities under the Credit Agreements were classified as current liabilities on the Consolidated Balance Sheet at July 31, 2024 and April 30, 2024. On August 19, 2024 (the “Third Amendment Effective Date”), the Lender Parties waived the 2024 Defaults pursuant to (i) the Waiver and Amendment No. 3 to Credit Agreement (the “JPM Amendment”) between the Company and JPM, and (ii) the Waiver and Amendment No. 3 to Credit <h1 dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;">Note A - Description of the Business - Continued</h1> Agreement (the “TCW Amendment” and together with the JPM Amendment, the “2024 Amendments”) by and among the Company, the TCW Lenders, and the Agent. In consideration of the TCW Amendment, the Company and the Agent also entered into the Third Amendment Fee Letter to the TCW Credit Agreement (the “Fee Letter”) dated as of the Third Amendment Effective Date. The 2024 Amendments also amended the financial covenants and certain other terms of the Credit Agreements, including, among other things, that the Company will pursue and close a Replacement Transaction (as defined in the Credit Agreements) to pay the obligations under the Credit Agreements in full no later than September 30, 2025 unless the Company meets certain debt ratios for the twelve month period ending on August 31, 2025. See Waivers and Amendments No. 3 within Note E – Long-term Debt for more information. The Company is taking steps to reduce its debt and cost structure. Most recently, since the beginning of calendar year 2024, these actions include the sale of its Elgin, Illinois property and consolidation of the Elgin operations to the Elk Grove Village, Illinois headquarters, reduction of headcounts at various operations and corporate, and inventory reduction. At this time, it is expected that these results plus the amendments to the financial covenants and other provisions of the Credit Agreements that are included in the 2024 Amendments should poise the Company for compliance. At the same time, the Company continues to explore other strategic initiatives to further reduce its debt to enable it to continue to comply with increasingly stringent financial covenants. Delays or a failure to effectively reduce debt, including due to circumstances outside of our control, could have an adverse effect on our financial position and results of operations.

CY2024Q3

us-gaap

Number Of Reportable Segments

NumberOfReportableSegments

1

CY2024Q3

us-gaap

Basis Of Accounting

BasisOfAccounting

Note B - Basis of Presentation The accompanying unaudited condensed consolidated financial statements of the Company, its subsidiaries, Standard Components de Mexico, S.A., AbleMex S.A. de C.V., Digital Appliance Controls de Mexico, S.A. de C.V., Spitfire Controls (Vietnam) Co. Ltd., and Spitfire Controls (Cayman) Co. Ltd., wholly-owned foreign enterprises Wujiang SigmaTron Electronics Co. Ltd., and Wujiang SigmaTron Electronic Technology Co., Ltd., its international procurement office, SigmaTron International Inc. Taiwan Branch, and Wagz, Inc. (majority of business sold, effective as of April 1, 2023), have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X.<h4 dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"> </h4><h4 dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;">The accompanying unaudited condensed consolidated financial statements do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the three month period ended July 31, 2024 are not necessarily indicative of the results that may be expected for the year ending April 30, 2025. The condensed consolidated balance sheet at April 30, 2024, was derived from audited annual financial statements but does not contain all of the footnote disclosures from the annual financial statements. For further information, refer to the condensed consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended April 30, 2024. </h4> Reclassifications Certain amounts recorded in the prior-period consolidated financial statements have been reclassified to conform to the current-period financial statement presentation. These reclassifications had no effect on previously reported results of operations.

CY2024Q3

us-gaap

Basis Of Accounting

BasisOfAccounting

Note B - Basis of Presentation The accompanying unaudited condensed consolidated financial statements of the Company, its subsidiaries, Standard Components de Mexico, S.A., AbleMex S.A. de C.V., Digital Appliance Controls de Mexico, S.A. de C.V., Spitfire Controls (Vietnam) Co. Ltd., and Spitfire Controls (Cayman) Co. Ltd., wholly-owned foreign enterprises Wujiang SigmaTron Electronics Co. Ltd., and Wujiang SigmaTron Electronic Technology Co., Ltd., its international procurement office, SigmaTron International Inc. Taiwan Branch, and Wagz, Inc. (majority of business sold, effective as of April 1, 2023), have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X.<h4 dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"> </h4><h4 dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;">The accompanying unaudited condensed consolidated financial statements do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the three month period ended July 31, 2024 are not necessarily indicative of the results that may be expected for the year ending April 30, 2025. The condensed consolidated balance sheet at April 30, 2024, was derived from audited annual financial statements but does not contain all of the footnote disclosures from the annual financial statements. For further information, refer to the condensed consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended April 30, 2024. </h4> Reclassifications Certain amounts recorded in the prior-period consolidated financial statements have been reclassified to conform to the current-period financial statement presentation. These reclassifications had no effect on previously reported results of operations.

CY2024Q3

us-gaap

Inventory Finished Goods

InventoryFinishedGoods

18882906

CY2024Q2

us-gaap

Inventory Finished Goods

InventoryFinishedGoods

18457912

CY2024Q3

us-gaap

Inventory Work In Process

InventoryWorkInProcess

4325983

CY2024Q2

us-gaap

Inventory Work In Process

InventoryWorkInProcess

4492609

CY2024Q3

us-gaap

Inventory Raw Materials

InventoryRawMaterials

94635445

CY2024Q2

us-gaap

Inventory Raw Materials

InventoryRawMaterials

108224069

CY2024Q3

us-gaap

Inventory Gross

InventoryGross

117844334

CY2024Q2

us-gaap

Inventory Gross

InventoryGross

131174590

CY2024Q3

us-gaap

Inventory Valuation Reserves

InventoryValuationReserves

2156689

CY2024Q2

us-gaap

Inventory Valuation Reserves

InventoryValuationReserves

2323689

CY2024Q3

us-gaap

Inventory Net

InventoryNet

115687645

CY2024Q2

us-gaap

Inventory Net

InventoryNet

128850901

CY2024Q3

us-gaap

Inventory Finished Goods

InventoryFinishedGoods

18882906

CY2024Q2

us-gaap

Inventory Finished Goods

InventoryFinishedGoods

18457912

CY2024Q3

us-gaap

Inventory Work In Process

InventoryWorkInProcess

4325983

CY2024Q2

us-gaap

Inventory Work In Process

InventoryWorkInProcess

4492609

CY2024Q3

us-gaap

Inventory Raw Materials

InventoryRawMaterials

94635445

CY2024Q2

us-gaap

Inventory Raw Materials

InventoryRawMaterials

108224069

CY2024Q3

us-gaap

Inventory Gross

InventoryGross

117844334

CY2024Q2

us-gaap

Inventory Gross

InventoryGross

131174590

CY2024Q3

us-gaap

Inventory Valuation Reserves

InventoryValuationReserves

2156689

CY2024Q2

us-gaap

Inventory Valuation Reserves

InventoryValuationReserves

2323689

CY2024Q3

us-gaap

Inventory Net

InventoryNet

115687645

CY2024Q2

us-gaap

Inventory Net

InventoryNet

128850901

CY2024Q3

us-gaap

Net Income Loss

NetIncomeLoss

-3289160

CY2023Q3

us-gaap

Net Income Loss

NetIncomeLoss

262099

CY2024Q3

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

6119288

CY2023Q3

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

6091288

CY2023Q3

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

8996

CY2024Q3

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

6119288

CY2023Q3

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.04

CY2024Q3

us-gaap

Net Income Loss

NetIncomeLoss

-3289160

CY2023Q3

us-gaap

Net Income Loss

NetIncomeLoss

262099

CY2023Q3

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

6091288

CY2023Q3

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

8996

CY2024Q3

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

6119288

CY2023Q3

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

6100284

CY2024Q3

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

-0.54

CY2023Q3

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.04

CY2024Q3

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

-0.54

CY2023Q3

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.04

CY2024Q3

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

691331

CY2023Q3

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

602081

CY2024Q3

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

0

CY2023Q3

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

186000

CY2024Q3

us-gaap

Stock Option Plan Expense

StockOptionPlanExpense

71174

CY2023Q3

us-gaap

Stock Option Plan Expense

StockOptionPlanExpense

184817

CY2024Q3

us-gaap

Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options

EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions

248321

CY2023Q3

us-gaap

Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options

EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions

530502

CY2024Q3

us-gaap

Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount

AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

120861

CY2023Q3

us-gaap

Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount

AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

379493

CY2024Q3

us-gaap

Debt Instrument Unamortized Discount Premium Net

DebtInstrumentUnamortizedDiscountPremiumNet

1407512

CY2024Q2

us-gaap

Debt Instrument Unamortized Discount Premium Net

DebtInstrumentUnamortizedDiscountPremiumNet

1528156

CY2024Q3

us-gaap

Long Term Debt

LongTermDebt

70743267

CY2024Q2

us-gaap

Long Term Debt

LongTermDebt

69583387

CY2024Q3

us-gaap

Long Term Debt Current

LongTermDebtCurrent

67785664

CY2024Q2

us-gaap

Long Term Debt Current

LongTermDebtCurrent

66244227

CY2024Q3

us-gaap

Long Term Debt Noncurrent

LongTermDebtNoncurrent

2957603

CY2024Q2

us-gaap

Long Term Debt Noncurrent

LongTermDebtNoncurrent

3339160

CY2024Q3

us-gaap

Finance Lease Liability

FinanceLeaseLiability

4748442

CY2024Q2

us-gaap

Finance Lease Liability

FinanceLeaseLiability

5361574

CY2024Q3

us-gaap

Finance Lease Liability Current

FinanceLeaseLiabilityCurrent

2087938

CY2024Q2

us-gaap

Finance Lease Liability Current

FinanceLeaseLiabilityCurrent

2214127

CY2024Q3

us-gaap

Finance Lease Liability Noncurrent

FinanceLeaseLiabilityNoncurrent

2660504

CY2024Q2

us-gaap

Finance Lease Liability Noncurrent

FinanceLeaseLiabilityNoncurrent

3147447

CY2024Q3

us-gaap

Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year

LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear

67375314

CY2024Q3

us-gaap

Long Term Debt Maturities Repayments Of Principal In Next Twelve Months

LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths

1328185

CY2024Q3

us-gaap

Long Term Debt Maturities Repayments Of Principal In Year Two

LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo

834557

CY2024Q3

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

-0.54

CY2023Q3

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.04

CY2024Q3

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

691331

CY2023Q3

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

602081

CY2024Q3

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

0

CY2023Q3

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

186000

CY2024Q3

us-gaap

Stock Option Plan Expense

StockOptionPlanExpense

71174

CY2023Q3

us-gaap

Stock Option Plan Expense

StockOptionPlanExpense

184817

CY2024Q3

us-gaap

Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options

EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions

248321

CY2023Q3

us-gaap

Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options

EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions

530502

CY2024Q3

us-gaap

Debt Instrument Unamortized Discount Premium Net

DebtInstrumentUnamortizedDiscountPremiumNet

1407512

CY2024Q2

us-gaap

Debt Instrument Unamortized Discount Premium Net

DebtInstrumentUnamortizedDiscountPremiumNet

1528156

CY2024Q3

us-gaap

Long Term Debt

LongTermDebt

70743267

CY2024Q2

us-gaap

Long Term Debt

LongTermDebt

69583387

CY2024Q3

us-gaap

Long Term Debt Current

LongTermDebtCurrent

67785664

CY2024Q2

us-gaap

Long Term Debt Current

LongTermDebtCurrent

66244227

CY2024Q3

us-gaap

Long Term Debt Noncurrent

LongTermDebtNoncurrent

2957603

CY2024Q2

us-gaap

Long Term Debt Noncurrent

LongTermDebtNoncurrent

3339160

CY2024Q3

us-gaap

Finance Lease Liability

FinanceLeaseLiability

4748442

CY2024Q2

us-gaap

Finance Lease Liability

FinanceLeaseLiability

5361574

CY2024Q3

us-gaap

Finance Lease Liability Current

FinanceLeaseLiabilityCurrent

2087938

CY2024Q2

us-gaap

Finance Lease Liability Current

FinanceLeaseLiabilityCurrent

2214127

CY2024Q3

us-gaap

Finance Lease Liability Noncurrent

FinanceLeaseLiabilityNoncurrent

2660504

CY2024Q2

us-gaap

Finance Lease Liability Noncurrent

FinanceLeaseLiabilityNoncurrent

3147447

CY2024Q3

us-gaap

Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year

LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear

67375314

CY2024Q3

us-gaap

Long Term Debt Maturities Repayments Of Principal In Next Twelve Months

LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths

1328185

CY2024Q3

us-gaap

Long Term Debt Maturities Repayments Of Principal In Year Two

LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo

834557

CY2024Q3

us-gaap

Long Term Debt Maturities Repayments Of Principal In Year Three

LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree

673231

CY2024Q3

us-gaap

Long Term Debt Maturities Repayments Of Principal In Year Four

LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour

466736

CY2024Q3

us-gaap

Long Term Debt Maturities Repayments Of Principal In Year Five

LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive

65244

CY2024Q3

us-gaap

Long Term Debt

LongTermDebt

70743267

CY2024Q3

us-gaap

Long Term Debt Maturities Repayments Of Principal In Year Three

LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree

673231

CY2024Q3

us-gaap

Long Term Debt Maturities Repayments Of Principal In Year Four

LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour

466736

CY2024Q3

us-gaap

Long Term Debt Maturities Repayments Of Principal In Year Five

LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive

65244

CY2024Q3

us-gaap

Long Term Debt

LongTermDebt

70743267

CY2024Q3

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

802213

CY2023Q3

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

-154135

CY2024Q3

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

-0.3226

CY2023Q3

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

-1.4276

CY2024Q3

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

7302639

CY2024Q3

us-gaap

Cumulative Earnings Deficit

CumulativeEarningsDeficit

14036000

CY2024Q3

us-gaap

Use Of Estimates

UseOfEstimates

Management Estimates and Uncertainties - The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates made in preparing the consolidated financial statements include depreciation and amortization periods, the allowance for credit losses, excess and obsolete reserves for inventory, deferred income, deferred taxes, uncertain tax positions, valuation allowance for deferred taxes and valuation of long-lived assets. Actual results could materially differ from these estimates. The potential impact of continued economic uncertainty due to persistent inflation and continuing global supply chain shortages and unpredictability may have a significant adverse impact on the timing of delivery of customer orders and the levels of future customer orders.

CY2024Q3

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

802213

CY2024Q3

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

-0.3226

CY2023Q3

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

-1.4276

CY2024Q3

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

7302639

CY2024Q3

us-gaap

Cumulative Earnings Deficit

CumulativeEarningsDeficit

14036000

CY2024Q3

us-gaap

Use Of Estimates

UseOfEstimates

Management Estimates and Uncertainties - The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates made in preparing the consolidated financial statements include depreciation and amortization periods, the allowance for credit losses, excess and obsolete reserves for inventory, deferred income, deferred taxes, uncertain tax positions, valuation allowance for deferred taxes and valuation of long-lived assets. Actual results could materially differ from these estimates. The potential impact of continued economic uncertainty due to persistent inflation and continuing global supply chain shortages and unpredictability may have a significant adverse impact on the timing of delivery of customer orders and the levels of future customer orders.

CY2024Q2

us-gaap

Allowance For Doubtful Accounts Receivable

AllowanceForDoubtfulAccountsReceivable

59466

CY2024Q3

us-gaap

Accounts Receivable Gross Current

AccountsReceivableGrossCurrent

35732628

CY2024Q2

us-gaap

Accounts Receivable Gross Current

AccountsReceivableGrossCurrent

32103451

CY2024Q3

us-gaap

Allowance For Doubtful Accounts Receivable

AllowanceForDoubtfulAccountsReceivable

7814

CY2024Q2

us-gaap

Allowance For Doubtful Accounts Receivable

AllowanceForDoubtfulAccountsReceivable

59466

CY2024Q3

us-gaap

Accounts Receivable Gross Current

AccountsReceivableGrossCurrent

35732628

CY2024Q2

us-gaap

Accounts Receivable Gross Current

AccountsReceivableGrossCurrent

32103451

CY2024Q3

us-gaap

Allowance For Doubtful Accounts Receivable Current

AllowanceForDoubtfulAccountsReceivableCurrent

7814

CY2024Q2

us-gaap

Allowance For Doubtful Accounts Receivable Current

AllowanceForDoubtfulAccountsReceivableCurrent

59466

CY2024Q3

us-gaap

Accounts Receivable Net Current

AccountsReceivableNetCurrent

35724814

CY2024Q2

us-gaap

Accounts Receivable Net Current

AccountsReceivableNetCurrent

32043985

CY2024Q3

us-gaap

Revenue From Contract With Customer Including Assessed Tax

RevenueFromContractWithCustomerIncludingAssessedTax

84776978

CY2023Q3

us-gaap

Revenue From Contract With Customer Including Assessed Tax

RevenueFromContractWithCustomerIncludingAssessedTax

98130356

CY2024Q3

us-gaap

Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized

ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized

0

CY2024Q3

us-gaap

Revenue Remaining Performance Obligation

RevenueRemainingPerformanceObligation

0

CY2024Q3

us-gaap

Allowance For Doubtful Accounts Receivable Current

AllowanceForDoubtfulAccountsReceivableCurrent

7814

CY2024Q2

us-gaap

Allowance For Doubtful Accounts Receivable Current

AllowanceForDoubtfulAccountsReceivableCurrent

59466

CY2024Q3

us-gaap

Accounts Receivable Net Current

AccountsReceivableNetCurrent

35724814

CY2024Q2

us-gaap

Accounts Receivable Net Current

AccountsReceivableNetCurrent

32043985

CY2024Q3

us-gaap

Revenue From Contract With Customer Including Assessed Tax

RevenueFromContractWithCustomerIncludingAssessedTax

84776978

CY2023Q3

us-gaap

Revenue From Contract With Customer Including Assessed Tax

RevenueFromContractWithCustomerIncludingAssessedTax

98130356

CY2024Q3

us-gaap

Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized

ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized

0

CY2024Q3

us-gaap

Revenue Remaining Performance Obligation

RevenueRemainingPerformanceObligation

0

CY2024Q2

us-gaap

Contract With Customer Liability

ContractWithCustomerLiability

3111062

CY2023Q2

us-gaap

Contract With Customer Liability

ContractWithCustomerLiability

8063197

CY2024Q3

sgma

Contract With Customer Liability Revenue Recognized Excluding Opening Balance

ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance

2612539

CY2023Q3

sgma

Contract With Customer Liability Revenue Recognized Excluding Opening Balance

ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance

4996715

CY2024Q3

us-gaap

Increase Decrease In Contract With Customer Liability

IncreaseDecreaseInContractWithCustomerLiability

2666475

CY2023Q3

us-gaap

Increase Decrease In Contract With Customer Liability

IncreaseDecreaseInContractWithCustomerLiability

2475787

CY2024Q3

us-gaap

Contract With Customer Liability

ContractWithCustomerLiability

3164998

CY2023Q3

us-gaap

Contract With Customer Liability

ContractWithCustomerLiability

5542269

CY2024Q2

us-gaap

Contract With Customer Liability

ContractWithCustomerLiability

3111062

CY2023Q2

us-gaap

Contract With Customer Liability

ContractWithCustomerLiability

8063197

CY2024Q3

sgma

Contract With Customer Liability Revenue Recognized Excluding Opening Balance

ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance

2612539

CY2023Q3

sgma

Contract With Customer Liability Revenue Recognized Excluding Opening Balance

ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance

4996715

CY2024Q3

us-gaap

Increase Decrease In Contract With Customer Liability

IncreaseDecreaseInContractWithCustomerLiability

2666475

CY2023Q3

us-gaap

Increase Decrease In Contract With Customer Liability

IncreaseDecreaseInContractWithCustomerLiability

2475787

CY2024Q3

us-gaap

Contract With Customer Liability

ContractWithCustomerLiability

3164998

CY2023Q3

us-gaap

Contract With Customer Liability

ContractWithCustomerLiability

5542269

CY2024Q3

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

7302639

CY2024Q3

us-gaap

Operating Lease Right Of Use Asset

OperatingLeaseRightOfUseAsset

7585366

CY2024Q2

us-gaap

Operating Lease Right Of Use Asset

OperatingLeaseRightOfUseAsset

7463301

CY2024Q3

us-gaap

Operating Lease Liability Current

OperatingLeaseLiabilityCurrent

3171681

CY2024Q2

us-gaap

Operating Lease Liability Current

OperatingLeaseLiabilityCurrent

2789107

CY2024Q3

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

7302639

CY2024Q3

us-gaap

Operating Lease Right Of Use Asset

OperatingLeaseRightOfUseAsset

7585366

CY2024Q2

us-gaap

Operating Lease Right Of Use Asset

OperatingLeaseRightOfUseAsset

7463301

CY2024Q3

us-gaap

Operating Lease Liability Current

OperatingLeaseLiabilityCurrent

3171681

CY2024Q2

us-gaap

Operating Lease Liability Current

OperatingLeaseLiabilityCurrent

2789107

CY2024Q3

us-gaap

Operating Lease Liability Noncurrent

OperatingLeaseLiabilityNoncurrent

4693774

CY2024Q2

us-gaap

Operating Lease Liability Noncurrent

OperatingLeaseLiabilityNoncurrent

4958247

CY2024Q3

us-gaap

Finance Lease Right Of Use Asset

FinanceLeaseRightOfUseAsset

6784837

CY2024Q2

us-gaap

Finance Lease Right Of Use Asset

FinanceLeaseRightOfUseAsset

6959660

CY2024Q3

us-gaap

Finance Lease Liability Current

FinanceLeaseLiabilityCurrent

2087938

CY2024Q2

us-gaap

Finance Lease Liability Current

FinanceLeaseLiabilityCurrent

2214127

CY2024Q3

us-gaap

Finance Lease Liability Noncurrent

FinanceLeaseLiabilityNoncurrent

2660504

CY2024Q2

us-gaap

Finance Lease Liability Noncurrent

FinanceLeaseLiabilityNoncurrent

3147447

CY2024Q3

us-gaap

Operating Lease Liability Noncurrent

OperatingLeaseLiabilityNoncurrent

4693774

CY2024Q3

us-gaap

Finance Lease Right Of Use Asset

FinanceLeaseRightOfUseAsset

6784837

CY2024Q2

us-gaap

Finance Lease Right Of Use Asset

FinanceLeaseRightOfUseAsset

6959660

CY2024Q3

us-gaap

Finance Lease Liability Current

FinanceLeaseLiabilityCurrent

2087938

CY2024Q2

us-gaap

Finance Lease Liability Current

FinanceLeaseLiabilityCurrent

2214127

CY2024Q3

us-gaap

Finance Lease Liability Noncurrent

FinanceLeaseLiabilityNoncurrent

2660504

CY2024Q2

us-gaap

Finance Lease Liability Noncurrent

FinanceLeaseLiabilityNoncurrent

3147447

CY2024Q3

us-gaap

Operating Lease Cost

OperatingLeaseCost

928834

CY2023Q3

us-gaap

Operating Lease Cost

OperatingLeaseCost

895469

CY2024Q3

us-gaap

Variable Lease Cost

VariableLeaseCost

51112

CY2023Q3

us-gaap

Variable Lease Cost

VariableLeaseCost

56900

CY2024Q3

us-gaap

Short Term Lease Cost

ShortTermLeaseCost

2850

CY2023Q3

us-gaap

Short Term Lease Cost

ShortTermLeaseCost

2250

CY2024Q3

us-gaap

Finance Lease Right Of Use Asset Amortization

FinanceLeaseRightOfUseAssetAmortization

682905

CY2023Q3

us-gaap

Finance Lease Right Of Use Asset Amortization

FinanceLeaseRightOfUseAssetAmortization

640847

CY2024Q3

us-gaap

Finance Lease Interest Expense

FinanceLeaseInterestExpense

131878

CY2023Q3

us-gaap

Finance Lease Interest Expense

FinanceLeaseInterestExpense

119686

CY2024Q3

us-gaap

Lease Cost

LeaseCost

1797579

CY2023Q3

us-gaap

Lease Cost

LeaseCost

1715152

CY2024Q3

us-gaap

Operating Lease Weighted Average Remaining Lease Term1

OperatingLeaseWeightedAverageRemainingLeaseTerm1

P38M17D

CY2023Q1

us-gaap

Operating Lease Weighted Average Remaining Lease Term1

OperatingLeaseWeightedAverageRemainingLeaseTerm1

P34M17D

CY2024Q3

us-gaap

Operating Lease Weighted Average Discount Rate Percent

OperatingLeaseWeightedAverageDiscountRatePercent

0.055

CY2023Q1

us-gaap

Operating Lease Weighted Average Discount Rate Percent

OperatingLeaseWeightedAverageDiscountRatePercent

0.034

CY2024Q3

us-gaap

Finance Lease Weighted Average Remaining Lease Term1

FinanceLeaseWeightedAverageRemainingLeaseTerm1

P29M29D

CY2024Q3

us-gaap

Operating Lease Cost

OperatingLeaseCost

928834

CY2023Q3

us-gaap

Operating Lease Cost

OperatingLeaseCost

895469

CY2024Q3

us-gaap

Variable Lease Cost

VariableLeaseCost

51112

CY2023Q3

us-gaap

Variable Lease Cost

VariableLeaseCost

56900

CY2024Q3

us-gaap

Short Term Lease Cost

ShortTermLeaseCost

2850

CY2023Q3

us-gaap

Short Term Lease Cost

ShortTermLeaseCost

2250

CY2024Q3

us-gaap

Finance Lease Right Of Use Asset Amortization

FinanceLeaseRightOfUseAssetAmortization

682905

CY2023Q3

us-gaap

Finance Lease Right Of Use Asset Amortization

FinanceLeaseRightOfUseAssetAmortization

640847

CY2024Q3

us-gaap

Finance Lease Interest Expense

FinanceLeaseInterestExpense

131878

CY2023Q3

us-gaap

Finance Lease Interest Expense

FinanceLeaseInterestExpense

119686

CY2024Q3

us-gaap

Lease Cost

LeaseCost

1797579

CY2023Q3

us-gaap

Lease Cost

LeaseCost

1715152

CY2024Q3

us-gaap

Operating Lease Weighted Average Remaining Lease Term1

OperatingLeaseWeightedAverageRemainingLeaseTerm1

P38M17D

CY2023Q1

us-gaap

Operating Lease Weighted Average Remaining Lease Term1

OperatingLeaseWeightedAverageRemainingLeaseTerm1

P34M17D

CY2024Q3

us-gaap

Operating Lease Weighted Average Discount Rate Percent

OperatingLeaseWeightedAverageDiscountRatePercent

0.055

CY2023Q1

us-gaap

Operating Lease Weighted Average Discount Rate Percent

OperatingLeaseWeightedAverageDiscountRatePercent

0.034

CY2024Q3

us-gaap

Finance Lease Weighted Average Remaining Lease Term1

FinanceLeaseWeightedAverageRemainingLeaseTerm1

P29M29D

CY2023Q1

us-gaap

Finance Lease Weighted Average Remaining Lease Term1

FinanceLeaseWeightedAverageRemainingLeaseTerm1

P32M15D

CY2024Q3

us-gaap

Finance Lease Weighted Average Discount Rate Percent

FinanceLeaseWeightedAverageDiscountRatePercent

0.103

CY2023Q1

us-gaap

Finance Lease Weighted Average Discount Rate Percent

FinanceLeaseWeightedAverageDiscountRatePercent

0.098

CY2024Q3

us-gaap

Lessee Operating Lease Liability Payments Remainder Of Fiscal Year

LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear

2682084

CY2024Q3

us-gaap

Finance Lease Liability Payments Remainder Of Fiscal Year

FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear

1912983

CY2024Q3

us-gaap

Lessee Operating Lease Liability Payments Due Next Twelve Months

LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths

3090111

CY2023Q1

us-gaap

Finance Lease Weighted Average Remaining Lease Term1

FinanceLeaseWeightedAverageRemainingLeaseTerm1

P32M15D

CY2024Q3

us-gaap

Finance Lease Weighted Average Discount Rate Percent

FinanceLeaseWeightedAverageDiscountRatePercent

0.103

CY2023Q1

us-gaap

Finance Lease Weighted Average Discount Rate Percent

FinanceLeaseWeightedAverageDiscountRatePercent

0.098

CY2024Q3

us-gaap

Lessee Operating Lease Liability Payments Remainder Of Fiscal Year

LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear

2682084

CY2024Q3

us-gaap

Finance Lease Liability Payments Remainder Of Fiscal Year

FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear

1912983

CY2024Q3

us-gaap

Lessee Operating Lease Liability Payments Due Next Twelve Months

LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths

3090111

CY2024Q3

us-gaap

Finance Lease Liability Payments Due Next Twelve Months

FinanceLeaseLiabilityPaymentsDueNextTwelveMonths

1989209

CY2024Q3

us-gaap

Lessee Operating Lease Liability Payments Due Year Two

LesseeOperatingLeaseLiabilityPaymentsDueYearTwo

971166

CY2024Q3

us-gaap

Finance Lease Liability Payments Due Year Two

FinanceLeaseLiabilityPaymentsDueYearTwo

1161407

CY2024Q3

us-gaap

Lessee Operating Lease Liability Payments Due Year Three

LesseeOperatingLeaseLiabilityPaymentsDueYearThree

715105

CY2024Q3

us-gaap

Finance Lease Liability Payments Due Year Three

FinanceLeaseLiabilityPaymentsDueYearThree

362983

CY2024Q3

us-gaap

Lessee Operating Lease Liability Payments Due Year Four

LesseeOperatingLeaseLiabilityPaymentsDueYearFour

729407

CY2024Q3

us-gaap

Lessee Operating Lease Liability Payments Due Year Five

LesseeOperatingLeaseLiabilityPaymentsDueYearFive

443414

CY2024Q3

us-gaap

Lessee Operating Lease Liability Payments Due

LesseeOperatingLeaseLiabilityPaymentsDue

8631287

CY2024Q3

us-gaap

Finance Lease Liability Payments Due

FinanceLeaseLiabilityPaymentsDue

5426582

CY2024Q3

us-gaap

Lessee Operating Lease Liability Undiscounted Excess Amount

LesseeOperatingLeaseLiabilityUndiscountedExcessAmount

765832

CY2024Q3

us-gaap

Finance Lease Liability Undiscounted Excess Amount

FinanceLeaseLiabilityUndiscountedExcessAmount

678140

CY2024Q3

us-gaap

Operating Lease Liability

OperatingLeaseLiability

7865455

CY2024Q3

us-gaap

Finance Lease Liability

FinanceLeaseLiability

4748442

CY2024Q3

us-gaap

Finance Lease Interest Payment On Liability

FinanceLeaseInterestPaymentOnLiability

131878

CY2023Q3

us-gaap

Finance Lease Interest Payment On Liability

FinanceLeaseInterestPaymentOnLiability

119686

CY2024Q3

us-gaap

Operating Lease Payments

OperatingLeasePayments

109363

CY2023Q3

us-gaap

Operating Lease Payments

OperatingLeasePayments

61121

CY2024Q3

us-gaap

Finance Lease Principal Payments

FinanceLeasePrincipalPayments

613132

CY2023Q3

us-gaap

Finance Lease Principal Payments

FinanceLeasePrincipalPayments

428105

CY2023Q3

us-gaap

Right Of Use Asset Obtained In Exchange For Finance Lease Liability

RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability

1032351

CY2024Q3

us-gaap

Right Of Use Asset Obtained In Exchange For Operating Lease Liability

RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability

936399

CY2023Q3

us-gaap

Right Of Use Asset Obtained In Exchange For Operating Lease Liability

RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability

1531

CY2024Q3

us-gaap

Finite Lived Intangible Assets Gross

FiniteLivedIntangibleAssetsGross

4690000

CY2024Q3

us-gaap

Finite Lived Intangible Assets Accumulated Amortization

FiniteLivedIntangibleAssetsAccumulatedAmortization

3792433

CY2024Q3

us-gaap

Finite Lived Intangible Assets Net

FiniteLivedIntangibleAssetsNet

897567

CY2024Q3

us-gaap

Finance Lease Liability Payments Due Next Twelve Months

FinanceLeaseLiabilityPaymentsDueNextTwelveMonths

1989209

CY2024Q3

us-gaap

Lessee Operating Lease Liability Payments Due Year Two

LesseeOperatingLeaseLiabilityPaymentsDueYearTwo

971166

CY2024Q3

us-gaap

Finance Lease Liability Payments Due Year Two

FinanceLeaseLiabilityPaymentsDueYearTwo

1161407

CY2024Q3

us-gaap

Lessee Operating Lease Liability Payments Due Year Three

LesseeOperatingLeaseLiabilityPaymentsDueYearThree

715105

CY2024Q3

us-gaap

Finance Lease Liability Payments Due Year Three

FinanceLeaseLiabilityPaymentsDueYearThree

362983

CY2024Q3

us-gaap

Lessee Operating Lease Liability Payments Due Year Four

LesseeOperatingLeaseLiabilityPaymentsDueYearFour

729407

CY2024Q3

us-gaap

Lessee Operating Lease Liability Payments Due Year Five

LesseeOperatingLeaseLiabilityPaymentsDueYearFive

443414

CY2024Q3

us-gaap

Lessee Operating Lease Liability Payments Due

LesseeOperatingLeaseLiabilityPaymentsDue

8631287

CY2024Q3

us-gaap

Finance Lease Liability Payments Due

FinanceLeaseLiabilityPaymentsDue

5426582

CY2024Q3

us-gaap

Lessee Operating Lease Liability Undiscounted Excess Amount

LesseeOperatingLeaseLiabilityUndiscountedExcessAmount

765832

CY2024Q3

us-gaap

Finance Lease Liability Undiscounted Excess Amount

FinanceLeaseLiabilityUndiscountedExcessAmount

678140

CY2024Q3

us-gaap

Operating Lease Liability

OperatingLeaseLiability

7865455

CY2024Q3

us-gaap

Finance Lease Liability

FinanceLeaseLiability

4748442

CY2024Q3

us-gaap

Finance Lease Interest Payment On Liability

FinanceLeaseInterestPaymentOnLiability

131878

CY2023Q3

us-gaap

Finance Lease Interest Payment On Liability

FinanceLeaseInterestPaymentOnLiability

119686

CY2024Q3

us-gaap

Operating Lease Payments

OperatingLeasePayments

109363

CY2023Q3

us-gaap

Operating Lease Payments

OperatingLeasePayments

61121

CY2024Q3

us-gaap

Finance Lease Principal Payments

FinanceLeasePrincipalPayments

613132

CY2023Q3

us-gaap

Finance Lease Principal Payments

FinanceLeasePrincipalPayments

428105

CY2023Q3

us-gaap

Right Of Use Asset Obtained In Exchange For Finance Lease Liability

RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability

1032351

CY2024Q3

us-gaap

Right Of Use Asset Obtained In Exchange For Operating Lease Liability

RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability

936399

CY2023Q3

us-gaap

Right Of Use Asset Obtained In Exchange For Operating Lease Liability

RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability

1531

CY2024Q3

us-gaap

Finite Lived Intangible Assets Gross

FiniteLivedIntangibleAssetsGross

4690000

CY2024Q3

us-gaap

Finite Lived Intangible Assets Accumulated Amortization

FiniteLivedIntangibleAssetsAccumulatedAmortization

3792433

CY2024Q3

us-gaap

Finite Lived Intangible Assets Net

FiniteLivedIntangibleAssetsNet

897567

CY2024Q2

us-gaap

Finite Lived Intangible Assets Gross

FiniteLivedIntangibleAssetsGross

4690000

CY2024Q2

us-gaap

Finite Lived Intangible Assets Accumulated Amortization

FiniteLivedIntangibleAssetsAccumulatedAmortization

3710812

CY2024Q2

us-gaap

Finite Lived Intangible Assets Net

FiniteLivedIntangibleAssetsNet

979188

CY2024Q3

sgma

Finite Lived Intangible Assets Fully Amortized Date

FiniteLivedIntangibleAssetsFullyAmortizedDate

2028

CY2024Q2

us-gaap

Finite Lived Intangible Assets Gross

FiniteLivedIntangibleAssetsGross

4690000

CY2024Q2

us-gaap

Finite Lived Intangible Assets Accumulated Amortization

FiniteLivedIntangibleAssetsAccumulatedAmortization

3710812

CY2024Q2

us-gaap

Finite Lived Intangible Assets Net

FiniteLivedIntangibleAssetsNet

979188

CY2024Q3

sgma

Finite Lived Intangible Assets Fully Amortized Date

FiniteLivedIntangibleAssetsFullyAmortizedDate

2028

CY2024Q3

us-gaap

Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year

FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear

243081

CY2024Q3

us-gaap

Finite Lived Intangible Assets Amortization Expense Next Twelve Months

FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths

317728

CY2024Q3

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Two

FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo

310900

CY2024Q3

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Three

FiniteLivedIntangibleAssetsAmortizationExpenseYearThree

25858

CY2024Q3

us-gaap

Finite Lived Intangible Assets Net

FiniteLivedIntangibleAssetsNet

897567

CY2024Q3

us-gaap

Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year

FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear

243081

CY2024Q3

us-gaap

Finite Lived Intangible Assets Amortization Expense Next Twelve Months

FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths

317728

CY2024Q3

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Two

FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo

310900

CY2024Q3

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Three

FiniteLivedIntangibleAssetsAmortizationExpenseYearThree

25858

CY2024Q3

us-gaap

Finite Lived Intangible Assets Net

FiniteLivedIntangibleAssetsNet

897567

CY2024Q3

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

81621

CY2023Q3

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

83415

Name	View Source	Status
0000915358-24-000017-index-headers.html	Edgar Link	pending
0000915358-24-000017-index.html	Edgar Link	pending
0000915358-24-000017.txt	Edgar Link	pending
0000915358-24-000017-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sgma-20240731.xsd	Edgar Link	pending
sgma-20240731x10q.htm	Edgar Link	pending
sgma-20240731x10qg001.jpg	Edgar Link	pending
sgma-20240731xex31_1.htm	Edgar Link	pending
sgma-20240731xex31_2.htm	Edgar Link	pending
sgma-20240731xex32_1.htm	Edgar Link	pending
sgma-20240731xex32_2.htm	Edgar Link	pending
Show.js	Edgar Link	pending
sgma-20240731_cal.xml	Edgar Link	unprocessable
sgma-20240731_def.xml	Edgar Link	unprocessable
sgma-20240731_lab.xml	Edgar Link	unprocessable
sgma-20240731_pre.xml	Edgar Link	unprocessable
sgma-20240731x10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SGMA
SIGMATRON INTERNATIONAL INC Stock $sgma

2024 Q3 Form 10-Q Financial Statement

#000091535824000017 Filed on September 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGMA SIGMATRON INTERNATIONAL INC Stock $sgma

2024 Q3 Form 10-Q Financial Statement

#000091535824000017 Filed on September 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGMA
SIGMATRON INTERNATIONAL INC Stock $sgma